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Summary 
Mitosis is a key step in the cell cycle process which is strongly regulated by reversible 
phosphorylation. In our study we used proteomic tools to understand the regulatory 
mechanisms of mitosis by studying phospho-regulation of kinases. We wanted to compare 
different stages of cell cycle progression with main focus on mitotic stages in terms of site-
specific kinase phosphorylation i.e. identification of phosphorylation sites on kinases and 
their relative dynamics during mitotic progression. We have done both large scale kinome 
studies using kinase enrichment as well as targeted studies focusing on single kinases 
(BubR1, Bub1).  
We first standardized methods for large scale synchronization of cells in different 
stages of the cell cycle. Using large scale kinome study to compare three mitotic states, i.e., 
prometaphase, metaphase and telophase, we generated a resource of information about 
phosphorylation dynamics for more than 900 kinase phosphorylation sites from 206 kinases. 
Around 25% of the kinase phosphorylation sites were found to be modulated by at least 50% 
during mitotic progression. Further network analysis of jointly regulated kinase groups 
suggested that cyclin-dependent kinase and mitogen-activated kinase centered interaction 
networks are coordinately down- and upregulated in late mitosis, respectively. MAP kinase 
activation is separately verified by western blot analysis. Importantly, being a global study 
our data provided a global view of the mitotic phospho-regulation of the kinome; and 
moreover identified attractive candidates for future studies of phosphorylation-based mitotic 
signaling apart from covering the already known events. 
Both BubR1 and Bub1 kinases were identified in the above study though the sequence 
coverage obtained was limited. We have chosen these kinases for detailed study due to their 
essential role in mitosis. We mapped phosphorylation sites on BubR1 and searched for the 
upstream kinase phosphorylating these residues. We demonstrated that BubR1 is 
phosphorylated by Cdk1 and that phosphorylation is required for BubR1 chromosome 
congression function. Since it is already established that Bub1 has kinase activity, we tried to 
identify the autophosphorylation sites on Bub1 and detected 15 sites that are 
autophosphorylated in-vitro. 
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1.0 Introduction 
 
1.1 Cell cycle 
Cell division is one of the fundamental processes required for survival and the continuation  
of life [1].  During cell division, the parent cell divides into two daughter cells capable of 
undergoing further divisions. The underlining goal of cell division is the faithful replication 
followed by equal segregation of genetic material. Eukaryotic cells are highly 
compartmentalized. Importantly, the nucleus, a double membrane compartment encapsulates 
the genetic material that is organized into chromatin, long supercoiled DNA structures in 
complex with a large variety of proteins, notably histones. Eukaryotic cell division proceeds 
through a number of discrete steps. First, cells prepare for cell division by interpreting 
various intra and extra-cellular signals. The decision to undergo cell division is a point of no 
return and cells remain committed for division or trigger apoptosis otherwise. Subsequently, 
the genetic material is replicated, followed by the equal distribution of cell contents to 
nascent daughter cells, and finally the physical separation of the daughter cells. Erroneous 
cell division is costly for organisms. Errors in the replication of genetic material compromise 
the integrity of the genome. Errors in chromosome segregation and physical separation lead 
to aneuploidy and polyploidy, fostering cell death and cancer. Fidelity of each step is guarded 
by multiple redundant pathways, ensuring the robustness of the whole process. These highly 
orchestrated series of events are collectively termed ‘cell cycle’ (Figure 1).  
 
1.2 Mitosis 
Mitosis is the most spectacular part of the cell cycle during which genetic material is 
equally divided between the two daughter cells. Mitosis consists of 5 stages, i.e., prophase, 
prometaphase, metaphase, anaphase and telophase (Figure 1). Cytokinesis, the physical 
separation of the daughter cells, follows mitosis. Mitosis together with cytokinesis is called 
M-phase. During prophase, the nuclear membrane breaks down and chromatin starts to 
condense into chromosomes. By prometaphase, condensed chromosomes are formed and 
centrosomes start emanating microtubules. In metaphase, all chromosomes are captured by 
the microtubules and brought to the center of the cell. Following this, chromosomes are 
moved to the opposite ends (anaphase). In the last stage (telophase) most of the changes that 
were initiated in the beginning of mitosis are reverted back to the initial state i.e. formation of 
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nuclear envelope, decondensation of the chromosomes etc. Mitosis is under tight regulation 
since chromosome segregation errors may result in cancer or cell death [1].  Interestingly, 
little or no protein synthesis takes place in mitosis and most of the mitotic events are 
regulated by protein phosphorylation and protein degradation[1]. 
 
 
Figure 1. Eukaryotic cell cycle with emphasis on mitotic stages. 
Representative pictures from different mitotic states are shown. Chromatin/chromosomes are stained 
with DAPI (Blue) whereas centrosomes and microtubules are stained by antibody coupled to alexa red 
(Red) and FITC (Green) respectively. The red arrow marks a mitotic spindle; and the white arrow 
points at a midbody.  
 
 
 
  
10 
 
1.2.1 Spindle assembly checkpoint                  
Physically, the segregation of sister chromatids into the two daughter cells is carried 
out by the mitotic spindle, a highly dynamic microtubule-based structure. Since proper 
bipolar attachment of chromosomes to spindle microtubules is essential for the correct 
segregation of chromosomes, this critical step is monitored by a signaling pathway, known as 
the spindle assembly checkpoint (SAC) [2]. The SAC is a ubiquitous safety mechanism that 
evolved in eukaryotes to avoid chromosomal segregation errors. It remains active and halts 
mitotic progression until the two sister kinetochores are bound to microtubules emanating 
from opposite poles, resulting in bi orientation (amphitelic attachment) (Figure 2). Elegant 
studies have shown that even single unattached kinetochores keep the SAC active and block 
the onset of anaphase [3].  In some cases, both kinetochores of a sister chromatic pair may be 
captured by microtubules emanating from the same centrosome, i.e. syntelic attachments, 
resulting in loss of tension between the kinetochores. Such mismatches also activate the SAC, 
giving the cells time to correct the mismatches. Thus, the SAC monitors both unattached 
kinetochores and tension between the kinetochores.  In mitotic HeLa cells, for example, SAC 
activity is turned on by adding either nocodazole which destabilizes the microtubules leading 
to attachment defects, or taxol which stablises the microtubules, leading to tension defects. 
However, not all kinetochore–microtubule attachment defects are detected by the SAC. Each 
kinetochore has binding sites for around 20-25 microtubules.  Therefore, a kinetochore may 
bind to microtubules from opposite poles (merotelic attachments). Merotelic attachments 
generate both tension and chromosome bi-orientation and hence are not detected by the SAC 
[4], thus leading to aneuploidy. However, both syntelic and merotelic attachments are 
corrected by Aurora B kinase mediated pathways[2]. 
 
1.2.2 The molecular mechanism of the SAC 
After DNA replication, sister DNA molecules/chromatids are held together by 
cohesion rings (Figure 2a). Removal of cohesin rings is thus mandatory for the separation of 
the sister chromatids.  Cohesin rings are cleaved by separase, a caspase like protease which is 
kept inactive by a protein called securin [5]. The anaphase promoting complex/cyclosome 
(APC/C) is an E3 ubiquitin ligase that marks target proteins for degradation by the 26S 
proteasome. Prior to anaphase, securin is ubiquitinated by the APC/C, thus initiating its 
degradation. This leads to separase activation and cleavage of cohesion rings separating the 
sister chromatids. The APC/C also initiates the degradation of Cyclin B. leading to the 
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A) Schematic representation of sister chromatids with amphitelic attachment. B) When the two sister 
kinetochores are bound to microtubules coming from opposite poles (Amphitelic attachment), tension 
is generated between the kinetochores, silencing the SAC, and the sister chromatids are pulled in 
opposite directions leading to normal chromosomal segregation. In cases where both the sister 
kinetochores are bound to microtubule coming from the same pole (Syntelic  attachment) or where a 
kinetochore is bound to microtubules from opposite poles rather than to just one pole (Merotelic 
attachment),chromosomal segregation errors may occur. Figure adopted from 
http://www.bch.msu.Edu/faculty /kuo/histoneH3mitoticprogression.jpg. 
 
1.3 Regulation of kinase by phosphorylation 
Reversible phosphorylation is a ubiquitous posttranslational protein 
modification,which is involved in the regulation of almost all biological processes [12; 13; 
14]. In humans, 518 protein kinases (PKs) have been identified in the genome; 
thesephosphorylate the majority of cellular proteins and increase the diversity of the 
proteome by several fold [15]. Addition of a phosphate group to a protein can alter its 
structural, catalytical, and functional properties; hence kinases require tight regulation to 
avoid unspecific phosphorylation which can be deleterious to cells [16; 17; 18]. As a result, 
cells employ a variety of mechanisms to ensure proper regulation of kinase activities [19]. 
Importantly, most kinases are also in turn regulated through auto-phosphorylation and 
phosphorylation by other kinases, thus generating complex phosphorylation networks. In 
particular, phosphorylation on activation segments is a common mechanism to modulate 
kinase activities [20; 21; 22], but additional phosphorylation sites are also frequently required 
for fine tuning of kinase activities [23]. Some kinases contain phosphopeptide binding 
domains which recognize pre-phosphorylated sites on other kinases, resulting in processive 
phosphorylation and/or targeting of kinases to distinct cellular locations [24; 25; 26; 27]. 
Since such priming phosphorylation events depend on the activities of the priming kinases, 
these motifs act as conditional docking sites and restrict the interaction with docking kinases 
to a particular point in time and physiological state. In addition, phosphorylation sites may act 
through combinatorial mechanisms or through crosstalk with other posttranslational 
modifications (PTMs) [28; 29], thus further increasing the complexity of kinase regulatory 
networks. 
Regulation of kinases is of particular interest in mitosis as most of the mitotic events 
are regulated by reversible protein phosphorylation [1]. Cyclin-dependent kinase 1 (Cdk1), an 
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evolutionarily conserved master mitotic kinase, is activated prior to mitosis and initiates most 
of the mitotic events. Cdk1 works in close association with other essential mitotic kinases 
such as Plk1, Aurora A and Aurora B for the regulation of mitotic progression [1; 30; 31; 32; 
33]. Plk1 and Aurora kinases dynamically localize to different subcellular locations to 
perform multiple functions during mitosis and are phosphorylated at several conserved sites. 
Although little is known about the precise roles of these phosphorylation sites, emerging data 
indicate that they are involved in regulating localization-specific functions [5; 34]. Further, 
the kinases Bub1, BubR1, TTK (Mps1), and kinases of the Nek family play important roles in 
maintaining the fidelity and robustness of mitosis [1]. Recently, a genome-wide RNA 
mediated interference screen identified M-phase phenotypes for many kinases which have not 
previously been implicated in cell cycle functions, indicating that additional kinases have 
important mitotic functions [35].  
 
1.4 Mass Spectrometry in biology  
Any instrument capable of measuring mass-to-charge ratio (m/z) of charged particles 
is called a mass spectrometer. Two particles with the same m/z move similarly in space and 
time when subjected to the same electric and magnetic fields. In other words, the motion of a 
charged particle under the influence of electromagnetic fields is unique and depends only on 
m/z. Mass Spectrometry (MS) makes use of this principle to  measure the m/z values of 
molecules. In MS the analytes are ionized to generate charged molecules and then the m/z of 
those molecules is measured. In general a mass spectrometer is composed of three principle 
components- an ion source, mass analyzer and a detector. Depending on the choice and 
configuration of these components, MS instrument are available in different forms with 
different capabilities. 
In 1912, the first MS instrument was constructed by J.J.Thomson, which was used to 
identify the isotopes of various elements. When the accuracy of the measurement is 
sufficient, it is possible to identify that ion by matching the measured m/z value to the values 
in a library (Identification). Fragmenting the molecule and measuring the m/z values of those 
fragments (MS/MS spectra) helps in elucidating the chemical structures of molecules, such as 
peptides (Primary structure identification). Fragmentation can be achieved by collision with 
inert gas molecules (collision induced dissociation, CID), electron capturing (electron capture 
disassociation, ECD) or by electron transfer (electron transfer dissociation, ETD). CID, the 
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most commonly used dissociation technique, produces b- and y- type peptide fragment ions 
and this is often sufficient to determine the peptide sequence. However, in case of PTMs, 
such as phosphorylation, CID preferentially cleaves the weakly bound PTM from the peptide, 
resulting in little fragmentation of the peptide backbone and making the identification of 
peptide sequence and/or the location of the modification difficult.  Alternatively, ETD 
induces fragmentation of the peptide backbone in a sequence independent manner, keeping 
the PTM intact and produces primarily c- and z-type fragment ions. Further, the intensity of 
the peptide in two or more samples can be compared from MS spectra (SILAC) or MS/MS 
spectra (iTRAQ) to estimate the relative abundance (Quantitation).  
Mass specrometers are rapid and robust; current instruments measure around 1-50 
mass spectra per second under typical workflows. Moreover, the sensitivity is in the 
attomolar range for peptides and they can be configured easily in high throughput workflows. 
These features of MS instruments changed the way in which biological molecules such as 
proteins, lipids and carbohydrates are analyzed. It paved path to fields like proteomics. MS 
become an invaluable tool for the identification of proteins, protein-protein interactions, post-
translational modifications and protein quantitation. Especially in recent years, tremendous 
advances in terms of instrument performance, methods efficiency, and computational power 
shifted the focus from small-scale projects to large-scale proteomic studies, allowing the 
study of the dynamics of proteomes in different cell types, under various stimuli, or under 
diverse experimental conditions. 
 
1.5 Mass spectrometric instrumentation 
 
1.5.1 Ion source 
Ion sources generates ions from the analytes, which are channeled to the mass 
analyzer. A variety of ionization techniques are available for mass spectrometry. Based on 
the physical state of the analyte, ion sources are classified in to three types, viz. gas, liquid 
and solid-state. Only liquid- and solid- phase ion sources are used for peptides as peptides are 
thermally unstable and do not have sufficient vapor pressure[36].  
In solid-state ion sources, such as matrix-assisted laser desorption/ionization 
(MALDI), the analyte is mixed with a matrix (commonly used matrixes are 3,5-dimethoxy-4-
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hydroxycinnamic acid, α-cyano-4-hydroxycinnamic acid and 2,5-dihydroxybenzoic acid)[37; 
38]. When the solvent is evaporated the analyte will co-crystallize with the matrix. These 
crystals are then irradiated by a laser, which ionizes the matrix molecules. The matrix then 
transfers its charge to the analyte molecules generating analyte ions. Further, apart from 
aiding the ionization of analyte molecules, the matrix also protects them from the disruptive 
energy of the laser.  
Electrospray ionization (ESI) is the best example for a liquid-phase ion source. This 
technique was introduced by John Bennett Fenn [39], for which he was awarded the Nobel 
Prize in 2002. In this method, the analyte is dissolved and passed through a narrow capillary 
tube at flow rates of 0.05-200 uL min-1. An electric potential (1-7 kV) is applied between the 
tip of the capillary and the opening of the mass specrometer, which are typically separated by 
0.3-3 cm. This induces charge accumulation at the tip of the capillary tube on the liquid drop 
that breaks the drop into highly charged smaller droplets. These droplets pass through a 
heated capillary which is at the opening of the MS instrument,where the solvent is evaporated 
leaving analyte ions. An inert gas like nitrogen is injected coaxially at low flow rates to limit 
the spatial dispersion of the spray. 
ESI has some characteristic features. Most importantly, it is able to generate multiply 
charged ions provided the molecules are large enough. Since the mass spectrometer measures 
only the m/z values and for a given instrument the measuring range is limited, multiply 
charged ions make analysis of large molecules such as proteins possible. ESI-trap instruments 
can measure m/z values between 50-2000Th. So proteins/peptides which are out of this range 
cannott be analyzed in their singly charged ionic states. However, for a protein of 20,000 kDa 
, for instance, the m/z value of a typical 20+ charge state is ~1,000 and falls within the range 
of the instrument. Another feature of ESI is that the number of ions generated is proportional 
to the concentration of the analyte and does not depend on the absolute amount. Further, the 
number of ions generated is sensitive to the solvent used and the electrolyte concentration in 
the solvent. One more advantage of the ESI source is that it can be seamlessly coupled to 
HPLC systems[36]. 
 
1.5.2 Mass analyzers 
Mass analyzers separate the ions that are generated by the ion source, according to 
their m/z. As there are many ion sources, different mass analyzers are also available, each 
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with specific advantages and disadvantages. All mass analyzers make use of static or 
dynamic electric and/or magnetic fields but differ in the way these fields are applied. They 
are broadly divided into two classes; first, scanning analyzers which transmit ions in a 
stepwise manner based on the m/z value, e.g., quadrupole and ion-trap mass analyzers. 
Second, simultaneous analyzers which transmit all the ions in one step, e.g., time of flight 
(TOF) and Orbitrap analyzers. It is possible to combine different types of mass analyzers in a 
single MS instrument. This offers versatility and better performance. Before opting for a 
mass analyzer there are at least five important features which have to be considered, i.e.  
measuring range, speed of analysis, transmission efficiency, mass accuracy and resolution.  
 
1.5.2.1 Linear quadrupole ion trap 
An ion trap is a device which traps ions in two or three dimensional space using direct 
current (DC) and radio frequency (RF) oscillating alternate current (AC) electric fields. The 
first generation of ion traps, the 3D ion trap was invented by Wolfgang Paul who was later 
awarded the Nobel Prize [40]. Linear quadrupole ion traps or 2D ion traps are second 
generation ion traps, which have improved features compared to 3D ion traps. The linear ion 
trap can function both as a storage device of ions for a period of time and as a mass analyzer. 
Linear ion trap is exemplified by the LTQ XL mass spectrometer  from Thermo Electron 
Corporation, the instrument that is used in this study. 
The LTQ linear trap is made up of two pairs of orthogonally positioned hyperbolic 
rods, which are cut into three sections. The central section is about three times larger (37 mm) 
than the two end sections. The side rods in the central section contain a slit along the z-axis 
through which ions can be ejected from the trap and the two detectors are placed facing the 
slits. 
  
Figure 3 Basic design of the linear quadrupole ion trap
A) Schematic representation of the linear quadrupole ion trap
2002). B) Schematic representation of linear quadrupole ion trap
masses (represented by different colors
from the trap in order of increasing mass
rods. The ions then strike the detection system
Hardware Manual, Thermo Electron Corporation, June 2006)
 
During the operation, DC
rods facing each other, whereas 
opposite polarities. Ions are trapped in axial direction by applying different 
the three sections. Further, the rods end in lenses 
and negative potential for negative ions
axially.  Ions are trapped in radial direction by applying the 
voltage) of the same amplitude but different polarities to the adjacent rods
In order to store ions in the ion trap
and axial directions simultaneously. 
by the Mathieu equation. Solving the Mathieu equation
17 
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Motion of ions inside a quadrupole trap can be described 
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In the above equations m is the ion mass; z is the ion charge. U and V are DC and RF 
potentials applied to the hyperbolic rods, respectively; ω is the angular frequency of the RF; 
r0 is the radius, i.e. half the distance between the opposite rods; au and qu are dimensionless 
trapping parameters in the Mathieu equation, which establish the relation between 
coordinates of ion and time; βu is a additional trapping parameter which is a complex function 
of au, qu (equation not shown). The values βu=0, βu=1 correspond to boundaries of stable 
regions, i.e. the point at which the trajectory of an ion becomes unstable[41]. 
The main RF voltage is ramped from low amplitude to high amplitude at constant 
voltage. Stability of an ion in radial direction depends on the main RF voltage i.e. the 
trajectory of an ion is stable only up to a certain RF voltage (resonance voltage)[42].  Initially 
a low RF voltage is applied allowing all the ions above a certain m/z values to be retained 
(storage voltage). Then, by ramping the main voltage at constant rate ions can be successively 
ejected in the order low to high m/z values. For MS/MS analysis, all the ions except the ion 
of interest should be ejected before the fragmentation. This is achieved with the help of ion 
isolation waveform voltages i.e. all resonance voltages except that of the ion of interest are 
applied[42]. Additionally, a resonance ejection AC voltage, i.e. fixed frequency with 
increasing amplitude, is applied during the ramping of the main RF voltage. When an ion is 
about to be ejected from the mass analyzer cavity by the main RF voltage, it approaches 
resonance with the resonance ejection AC voltage. As a result ions move away from the 
center into a region where the field produced by the main RF voltage is strong, thus 
enhancing the ejection of the ion and improving the mass resolution [42]. 
Linear ion-traps offer many advantages over 3D traps; 15 times higher ion capacity, 3 
times faster scan rate, up to 100% detection efficiency, and up to 70% trapping efficiency. 
However, the mass accuracy of ion traps is in the range of 0.2-2.0 Da and resolution less than 
1,000 (at high scanning speed). 
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1.5.2.2 The electrostatic trap or orbitrap 
The orbitrap is an electrostatic trap that was developed from a completely new 
concept, proposed by Makarov [43; 44], and was commercially released by Thermo Electron 
Corporation in 2005. The orbitrap mass analyzer quickly gained popularity due to its superior 
mass accuracy (low ppm or ppb) and high resolution (upto 1,00,000) without requiring any 
powerful magnets. It uses fourier transformation to obtain the mass spectra. 
The design of the orbitrap consists of a central spindle shaped electrode (maximum 
diameter of 8 mm) surrounded by a barrel shaped external electrode. The external electrode is 
made by two equal half’s which are kept at a small distance. DC voltage of several kilovolts 
is applied to the central electrode, negative for positive ions and positive for negative ions 
and the external electrode is at ground potential [36]. Ions enter the trap tangentially through 
this gap with a kinetic energy of few kiloelectronvolts and start oscillating. Ions follow 
intricate paths inside the trap under the influence of a quadro-logarithmic field, due to the 
peculiar geometry of the trap. The angular frequency (ω) of an ion inside the trap is given by 
          (k is field curvature) 
This equation is of great interest as it implies that the frequency is directly linked to the ratio 
of q/m and independent of the initial kinetic energy. As a result, by measuring the frequency 
of an ion inside the orbitrap, its m/z value can be calculated. 
 
Figure 4. Cross section of orbitrap mass analyzer (courtesy, Thermo Electron Corporation ).  
 
Inner 
electrode 
Outer 
electrode 
Ion trajectory 
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1.5.3 Detectors  
Detectors generate an electric current proportional to the number of ions reaching 
them (impact detectors). This electric current is then used to measure the relative intensity. A 
variety of impact detectors suiting to different mass analyzers are available.  
The LTQ MS is equipped with an off-axis detection system (Figure 3). Ions ejected 
from the ion trap hit two conversion dynodes which are placed perpendicular to the ion exit, 
producing secondary particles. Positive secondary particles are of interest for negative ions 
and vice versa. The concave shape of the dynode helps in focusing the ions which are 
channeled through an electron multiplier.  The electron multipliers generally operate at a gain 
of 105. The current that is leaving the electron multiplier is converted to voltage by an 
electrometer and is recorded. Since the detection system is placed off-axis to the mass 
analyzer, neutral molecules will not reach the conversion dynode thus avoiding noise. 
The detectors in Fourier transform ion cyclotron resonance (FTICR) or Orbitrap 
analyzers are different from impact-type detectors. These detectors measure the broadband 
current that is generated by the oscillating ions present in the trap. This image current is later 
resolved in to individual frequencies using the mathematical Fourier transformation. 
 
1.6 Methods for quantitation  
Mass spectrometry based quantitative methods can be broadly classified as label free 
and label based methods. Label free methods are simple and inexpensive as they do not 
involve any additional steps in the experimental design or reagents. Ideally, the intensity 
value in the mass spectrum should be sufficient to perform relative quantitation. However, 
ionization of an ion depends on multiple factors including the complexity of the sample. This 
coupled together with variations in liquid chromatography (LC) profiles leads to large run-to-
run variation. Thus, label free methods are less reliable and mostly qualitative (eg. spectral 
counting). It is important to note that label free methods which make use of identified 
peptides to correct the variation in LC profiles along with replicates tend to be more accurate 
[45; 46]. Further, mass accuracy and resolution of the data are very important for any 
quantitative method. Thus FT instruments are preferred over ion trap instruments. 
Label based methods introduce a label into the sample either chemically (iTRAQ, 
ICAT) or metabolically (SILAC).  The label can be either isotopic or isobaric. In case of 
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isotopic labeling the label introduced into the sample and the control differ by few Daltons. 
As a result, the peptides show up as doublets in the MS spectrum. Isobaric labeling works 
slightly differently.  The mass of the sample and the control would be the same after labeling. 
However, when these peptides are fragmented, they release reporter ions of different m/z, i.e. 
quantitation is achieved through MS/MS spectra. 
  Isotopic labeling is exemplified by stable isotope labeling with amino acids in cell 
culture (SILAC). SILAC is developed mainly for cultured  cell lines; however recent studies 
have shown that it can be successfully extended to popular model systems such as mice(Mus 
musculus), drosophila (Drosophila melanogaster), yeast (Saccharomyces cerevisiae), etc [47; 
48; 49]. In this method, natural amino acids (commonly arginine and lysine) containing C13, 
N15 and H2 isotopes act as labels [50]. Cells are grown in culture media that are devoid of 
those amino acids which need to be labeled. Commonly used media are Dulbecco’s Modified 
Eagle’s Medium (DMEM) and RPMI-1640 without labeling amino acids. Labeled amino 
acids are separately added to the medium and are incorporate into the proteins using cells 
own translation machinery. All 20 amino acids are available in isotopic labeled forms.  
Arginine and lysine are the preferred choices, because trypsin cleaves after arginine and 
lysine residues making sure that every peptide will contain at least one arginine or lysine 
except the peptide containing the protein C-terminus. Further, arginine and lysine are 
essential amino acids for human cell lines i.e. they cannot be synthesized internally. This 
ensures complete labeling of the proteome (>97%). For simple quantitative analyses, (e.g., 
protein quantitation in a simple protein mixture) labeling with one amino acid might be 
sufficient. However, if all the peptides need to be quantified, such as for PTM analysis, both 
arginine and lysine should be used for tryptic protein digests. Moreover, normal fetal calf 
serum (FCS) contains many amino acids, including arginine and lysine. Hence dialyzed FCS 
is necessary for complete labeling of proteins. SILAC quantitation is more reproducible than 
the methods using chemical labels. First, as opposed to chemical labeling, SILAC labeling is 
achieved prior to cell lysis. As a result, cells from sample and control can be mixed and 
processed together, minimizing variation arising from downstream steps. Second, 
quantitation is achieved through MS spectra acquired during the peptide elution (which are 
often more than one) as opposed to MS/MS spectra (which are often one per m/z). However, 
the main limitation of the SILAC method is that it cannot be used to analyze harvested tissue 
samples.  
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1.7 Phosphoproteomics 
Phosphorylation is one of the most common reversible  post translational 
modifications of proteins. In mammals, phosphorylation occurs mainly on serine, threonine 
and tyrosine residues. Although many proteins are phosphorylated, not all molecules of a 
given population are phosphorylated. Furthermore, only 1-2 % of peptides are usually 
phosphorylated, making prior enrichment mandatory for their detection [51]. Many methods 
were proposed for the enrichment of phosphopeptides. Immobilized metal-ion affinity 
chromatography (IMAC), which was originally developed for purification of His-tagged 
proteins, was extended to phosphopeptides [52]. Phospho groups are negatively charged, 
hence they bind to positively charged metal ions such as Fe3+, Ga3+, Al3+ or Zr4+ through 
electrostatic interactions.  As a main drawback, IMAC is highly sensitive to the salt 
concentration in the sample and prior desalting steps are necessary. On the other hand, metal-
oxide chromatography (MOC) using titania, zirconia, and alumina was shown to be tolerant 
to salts in the sample [53]. Ideally, for comprehensive coverage of the phosphoproteome both 
methods are incorporated into the workflow [54].  
Successful enrichment of phosphpeptides depends on many factors. Non-specific 
binding of acidic peptides to the metal oxide is a major bottleneck. It was shown that 
nonspecific binding can be reduced by using low pH and by introducing appropriate aliphatic 
hydroxy acid (i.e. modifier). At low pH all the carboxyl groups will be protonated and the 
modified molecules compete with acidic peptides for binding to the metal oxide. Titanium 
dioxide with lactic acid or glycolic acid as modifiers give good results [55]. 
Elution of the phosphopeptides from the metal dioxide is a non trivial step. Peptides 
are eluted by changing the pH of the solution to alkaline. Ammonia solution is the preferred 
choice for phosphopeptide elution but recent studies suggested that for complete elution of 
peptides, especially multiply phosphorylated peptides, more than one basic reagent is 
necessary. Successive elution with ammonia, piperidine and pyrolidine is shown to be more 
effective to achieve efficient elution [56].  
In addition to IMAC and MOC many other methods have been developed to detect 
phosphopeptides selectively, including strong cation exchange (SCX) chromatography [57] 
and MS based methods such as precursor ion scanning in the negative mode [58], neutral loss 
triggered MS3 [59], and pseudo-MS3 [60]. 
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Once the phosphopeptide is identified by MS, a next important step is to identify the 
precise location of the phosphorylation site within the peptide. Information about actual 
phosphorylation sites  biologically more meaningful than information about phosphopeptides. 
When the peptide sequence contains more than one serine/threonine/tyrosine residue, 
phosphorylation needs to be assigned to the correct residue, using  peptide fragmentation data 
in the MS/MS spectra. However, gaps in the MS/MS ion series as well as close spacing of the 
serine/threonine/tyrosine residues often complicate the precise determination of the 
phosphorylation sites. Hence, for each possible phosphorylation site a probability value is 
assigned (localization probability) and generally phosphorylation sites with localization 
probabilities exceeding 75% are considered valid [57]. 
 
1.8 Bioinformatic tools for the analysis of mass spectrometry data 
Over the past decade, proteomics has  undergone a shift from qualitative to 
quantitative strategies and has emerged as a method-of-choice for analyzing the dynamics of 
proteomes in different cell types, under various stimuli, or under diverse experimental 
conditions [61]. As a consequence, the amount of published proteomic data has increased 
rapidly and in-depth analysis of large-scale proteomic datasets is becoming more and more 
important as the interest in proper biological interpretation of the data is increasing. Gene 
ontology, pathway analysis and  protein-protein interaction analysis emerged as invaluable 
tools to convert large datasets into knowledge of biological significance. 
 
1.8.1 Gene ontology 
While describing a particular protein or function, researchers often do not use  terms 
consistently. This is now overcome by the use of controlled ontology called Gene Ontology 
(GO)[62]. Every gene/protein can thus be described by a finite vocabulary at different levels 
of granularity. Within GO, a limited set of species-independent terms are available, thus 
strongly reducing ambiguities. Each GO-entry consists of a number (GO-identifier) and a 
term associated with it. Each term can then belong to one of the three GO-categories, namely 
‘biological process’, ‘molecular function’ or ‘cellular component’. It is important to note that 
GO is structured in a hierarchical way. Each term constitutes a node in a directed acyclic 
graph, with one or more parent terms and one or more child nodes.  
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GO-term analysis often constitutes the most basic step in the bioinformatic 
characterization of proteomic datasets. A simple way to analyze the data is to annotate the 
proteins with GO-terms and determine whether they show enrichment for a particular group 
of biological processes, functions or cellular compartments. Several tools are available to 
accomplish this task; an extensive list of GO-related tools can be found at 
http://www.geneontology.org/GO.tools.microarray.shtml. Moreover, these tools often serve 
as meta-tools in that they not only search for GO terms, but also integrate information from 
pathways, domains and other important biological attributes. DAVID is an example of such a 
popular meta-tool [63] that helps to detect over- or under-represented GO terms within a 
dataset.  
 
1.8.2 Pathway analysis 
 A biological pathway consists of a series of well defined reactions among 
biomolecules which will result in a specific biological outcome. As pathways focus on 
physical and functional interactions between proteins rather than merely taking the gene-
centric view of GO-based analyses, pathway analyses have the potential to take the analysis 
of proteomic data one step further. Pathway analysis using proteomic data is extremely useful 
in areas such as signal transduction, metabolic processes, and cell cycle progression, which  
involve extensive regulation at the protein level (i.e. by posttranslational modifications) and 
thus cannot be comprehensively studied by mRNA expression analysis alone. Pathway 
models are manually curated and are iteratively refined to keep up-to-date with the emerging 
scientific data. Manual annotation mainly focuses on well-known and well-studied pathways, 
thus possibly leaving out pathways which may be potentially interesting for other researchers.  
Metabolic pathways are well established compared to signaling pathways, mostly because 
they are actively constructed by a number of dedicated groups [64].  
 Currently, around 300 pathway resources are available. Some of the popular and 
freely available pathway databases are KEGG[65], Reactome[66], STKE[67], 
PANTHER[68], Biomodels[69], GenMAPP[70], and PID[71]. Over-representation analysis 
is often used to annotate the protein lists of interest, in a similar way as mentioned above in 
the gene ontology section, especially when analyzing data from proteome states measured 
under different conditions. Meta-tools such as DAVID, PANTHER [68] and Babelomics [72] 
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provide over-representation analysis of GO terms, domains and pathways. In addition, they 
cluster similar/relevant annotations in the results in order to reduce the redundancy of terms.  
 
1.8.3 Interaction networks 
Proteins work rarely in isolation but rather function in complexes as multi-protein 
machines. Since their assembly is largely mediated by protein-protein interactions (PPIs), 
functional modules within a proteome may be revealed by PPI analyses[73]. In general, PPIs 
comprise both physical and functional interactions, which may be further grouped into 
experimentally determined and computationally predicted interactions. Functional 
interactions include sharing a common substrate in a pathway, regulating each other at the 
transcriptional level, or indirect binding through participation in larger multi-protein 
assemblies [74]. HPRD [75], IntAct [76], MINT [77], BIND [78], DIP [79], and BioGRID 
[80] are some of the popular databases covering experimentally obtained PPIs, derived from a 
combination of automatic extraction and expert curation.  
STRING is a powerful meta-database incorporating data from many curated databases 
(IntAct, BioGRID, HPRD, MINT, DIP and BIND), additional in-silico predicted interactions 
and additional pathway information with an easy-to-use web interface. STRING thus 
constitutes a very popular tool for interaction network analysis of proteomic data. It 
incorporates experimentally derived interactions from the above databases along with 
interactions obtained from computational predictions and text mining. Importantly, the types 
of included interactions can be easily specified by the user for any given analysis, thus 
allowing different levels of stringency. Lists of proteins can directly serve as an input to 
STRING, so that all known interactions as well as hub-proteins can easily be extracted. 
However, when interpreting the predicted interactions one has to be very careful to select the 
right parameters and types of interaction data.. 
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2.0 Results (Part 1): Phosphorylation dynamics of protein kinases across mitosis* 
*This work is included in a manuscript that has been accepted for publication: Quantitative site-
specific phosphorylation dynamics of human protein kinases during different mitotic stages. Kalyan 
Dulla, Henrik Daub, Renate Hornberger, Erich A. Nigg, Roman Körner. Molecular & Cellular 
Proteomics (2010), in press. 
I would like to state that kinase enrichment from the cell lysates was performed in 
collaboration with Dr. Henrik Daub and Frau Renate Hornberger (MPIB). All the other 
upstream and downstream experiments were performed by myself. 
 
2.1 Introduction 
 Although protein phosphorylation plays a pivotal role in the regulation of cellular 
networks, many phosphorylation events remain undiscovered mainly due to technical 
limitations [81]. The advent of mass spectrometry based proteomics along with developments 
in phosphopeptide enrichment methods has enabled large scale global phosphoproteomic 
studies [55; 82]. However, the number of phosphorylation sites identified on kinases is 
limited compared to other proteins due to their frequently low expression levels. In order to 
overcome this problem, small inhibitor based kinase enrichment strategies were developed 
resulting in the identification of more than 200 kinases from HeLa cell lysates [83; 84]. This 
method was also used recently to compare the phospho-kinomes during S-phase and M-phase 
of the cell cycle resulting in the identification of several hundreds of M-phase specific kinase 
phosphorylation sites [83]. In the present study, we address the dynamics of the phospho-
kinome during mitotic progression using large scale cell synchronization at three distinct 
mitotic stages, small inhibitor based kinase enrichment and SILAC based quantitative mass 
spectrometry. Thus we have determined the mitotic phosphorylation dynamics of more than 
900 kinase phosphorylation sites, and identified distinctly regulated kinase interaction 
networks. Our results provide a valuable resource for the dynamics of the kinome during 
mitotic progression and give insight into the systems properties of kinase interaction 
networks. 
 
2.2 Experimental strategy 
  SILAC is amongst the preferred methods for comparative proteomic studies in 
mammalian cell lines and provides easy and accurate quantitation [50; 85]. In the present 
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study, we used SILAC triple labeling in combination with small inhibitor based kinase 
enrichment and large scale cell synchronization methods (Figure 5). In brief, three 
populations of HeLa cells were grown in large scale under identical conditions using spinner 
cultures in light, medium and heavy SILAC media containing different isotopic forms of 
arginine and lysine. Next, cells were synchronized in prometaphase, metaphase and telophase 
using the drugs nocodazole and MG132 (Figure 5) and the three cell populations were lysed 
and mixed in equal proportions. From the lysate, cellular protein kinases were enriched using 
kinase affinity chromatography and fractionated by one dimensional SDS-PAGE followed by 
tryptic digestion of the proteins. Alternatively, the enriched kinase fraction was in-solution 
digested by trypsin and fractionated using SCX. All fractions were enriched for 
phosphopeptides using TiO2 and measured by nanoLC-MS/MS. Flowthrough fractions 
remaining after phosphopeptide enrichment were also analyzed for calculating protein ratios. 
To address the biological reproducibility, experiments were carried out in triplicate. 
 
2.3 Large scale synchronization of HeLa cells in different mitotic stages 
HeLa cell lines are popular model systems for mammalian cell cycle research and are 
often used in large scale proteomics studies [83; 86]. Established protocols for HeLa 
synchronization at specific mitotic stages, however, are optimized for adherent HeLa cell 
lines, which are not compatible with the large amounts of cells needed for kinase enrichment. 
Therefore, we developed mitotic synchronization protocols for HeLa Suspension (HeLa S) 
cells, which can be grown on a sufficiently large scale in suspension (spinner) cultures. To 
assure HeLa S undergoes normal cell cycle, growth kinetics were studied and 
immunofluorescence pictures after DNA and α-Tubulin staining microscopy pictures were 
taken across the cell cycle. These results demonstrate that HeLa S cells faithfully mimic the 
normal cell cycle and can be synchronized with traditional mitotic inhibitors (Figure 6). 
Double synchronization with thymidine in S-phase followed by treatment with 
microtubule destabilizing drugs such as nocodazole is the preferred method to enrich HeLa 
cells in mitosis. Nocodazole is a reversible inhibitor which efficiently arrests the cells in a 
prometaphase like state with an active SAC. Generally, drug induced mitotic states mimic 
natural mitotic stages but may not perfectly represent unperturbed mitosis. However, 
synchronization with thymidine and nocodazole are accepted methods in biological studies of 
mitosis and our current knowledge of mitotic progression is to a large extent based on the use 
of these drugs for synchronization. To reduce possible side effects to a minimum, we used a 
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single thymidine block instead of the double thymidine arrest.  Also for the nocodazole and 
MG132 synchronization steps, we have carefully determined the minimal concentrations and 
incubation times of the drugs to reduce possible side effects.  
Various nocodazole concentrations were tested and 40-50 ng/ml were found sufficient 
to block HeLa S cells in mitosis. For adherent nocodazole treated HeLa cell cultures, the 
purity of the mitotic cell fraction can be strongly increased by shake-off of the rounded 
mitotic cells. Unfortunately, this shake-off method cannot be applied to cells grown in 
suspension and we therefore tried other means to increase the purity of mitotic HeLa S cells. 
Assuming that an increase of the growth stimulus may help cells reaching prometaphase 
faster and thus more synchronously, nocodazole was applied to media with increased 
concentrations of FCS. As expected, cells supplemented with higher concentrations of FCS 
(20%) entered into mitosis more coherently with more than 90% of cells reaching 
prometaphase within 12 hours of thymidine release (Figure 7B). Next, to enrich cells in 
metaphase, MG132, a reversible cell permeable proteasome inhibitor, was employed. This 
drug blocks proteasome mediated degradation of Securin which is required for progression to 
anaphase. Importantly, cells blocked by MG132 are characterized by an inactivated SAC 
providing the opportunity to study SAC signaling by comparison with nocodazole blocked 
cells with an active SAC. Thus approximately 90 % of the MG132 blocked cells were 
determined to be in metaphase. Finally, to enrich for the telophase state, cells were released 
from MG132 and the optimal time to harvest telophase cells was determined by 
immunofluorescence microscopy of DNA stained cell fractions at various time points. 
Synchronization in telophase turned out to be the most difficult and least reproducible task 
since this stage is rather short (typically 20-30 minutes) and there are no drugs available to 
block cells efficiently in telophase. HeLa cells released from MG132 enter telophase after 
approximately 90-120 minutes (release time from the metaphase block and anaphase). This 
duration is slightly longer than in unperturbed mitosis as the cells take some time to recover 
from the MG132 block. After optimization of the release period, 45 %, 60 %, and 70 % 
telophase cells were counted in experiment 1, experiment 2, and experiment 3, respectively 
(Figure 7B). 
We further benchmarked the samples using western blot analysis of various mitotic 
markers (Figure 7D). The concentrations of Cyclin B and Securin are known to be low in S-
phase, to peak in prometaphase and metaphase, and to be quickly diminished in anaphase 
after inactivation of the SAC. As shown in Figure 7D, western blot analyses of the 
synchronized HeLa S cells are fully consistent with the expected expression levels. 
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Phosphorylation of Ser10 of Histone H3 is a marker for chromosome condensation. Since 
anti-pSer10 staining is not diminished in the telophase sample (Figure 7D), we conclude that 
cells did not enter the next G1 cycle yet. Further, BubR1 pSer676 has been shown to be 
phosphorylated in prometaphase but not in metaphase[87] so the western blots in Figure 7D 
demonstrate a good separation between prometaphase and metaphase enriched cells. In 
summary, the western blot results along with the immunofluorescence pictures (Figure 7B) 
show that the samples faithfully represent the mitotic stages prometaphase, metaphase and 
telophase. 
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Figure 5. Schematic overview of the 
experimental strategy 
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Figure 6. Characterization of the HeLa S cell line. 
A) Picture of HeLa S cells on cell culture dishes. B) Growth curve of HeLa S cells. C) Representative 
immunofluorescence pictures of HeLa S cells across different stages of the cell-cycle in the order 
interphase, prometaphase, metaphase, anaphase, telophase and cytokinesis. DNA and Tubulin are 
stained in blue and green, respectively. Scale bars represent 10 µm. 
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 Figure 7. Outline and quality control of the cell synchronization procedure 
A) Eukaryotic cell cycle with emphasis on mitotic stages. Centrosomes are shown as red dots, 
chromosomes are depicted in blue, and microtubules are displayed in green. The employed 
synchronization steps are indicated in the diagram with inward and outward directed arrows marking 
the addition and release of drugs. T and N refer to thymidine and nocodazole, respectively. B) 
Representative pictures from prometaphase, metaphase and anaphase cells. The yellow arrow 
highlights a microtubule cluster; the pink arrow marks a mitotic spindle; and the white arrow points at 
a midbody, scale bars represent 10 µm. C) Synchronization efficiencies were plotted as counted from 
the images.D) Western blot analyses of the samples using various mitotic markers. P stands for 
prometaphase samples obtained from nocodazole block (Stage 1), M represents metaphase samples 
from a MG132 (Stage 2) block, T marks telophase (Stage 3) samples from MG132 release, and S- 
stands for thymidine blocked HeLa cells in S-phase. The S-phase stage is not part of the proteomics 
experiment but was included in the western blot analyses as a reference. 
2.4 Identification of proteins and phosphorylation sites 
 The experiments carried out in biological triplicates resulting in 117 raw files with 
555,444 MS/MS spectra, making data analysis computationally and technically challenging. 
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Analysis of SILAC data was done in a fully automated manner using the MaxQuant software 
suite (version 1.0.12.5)[45] in association with the MASCOT search engine [88]. To ensure 
the fidelity of protein and phosphorylation site identifications, the decoy database strategy 
was used to minimize false positive rates (FDR) [89]. Peptide sequences were assigned for 
one third of the MS/MS spectra at a FDR of 0.01. We used a conservative approach for 
calculating the number of proteins and phosphopeptides identified in our study. All the 
peptide isoforms (SILAC and PTM’s) matching to a single sequence were counted as one and 
all the proteins which share common peptides were grouped into one protein group [45]. 
Distinguishing protein kinases from other proteins turned out to be a complex task, as 
multiple isoforms and splice variants are annotated for many kinases in the IPI database. 
Therefore, we strictly adhered to the kinase sequences provided by Manning and coworkers. 
(KinBase database version 08.02) [15] [90] and kinase peptides were identified by matching 
identified peptide sequences to kinase sequences. Later, these peptides were assembled into 
proteins essentially as described for the MaxQuant algorithm. The efficiency of the 
enrichment for kinases is demonstrated by the large number of kinase identified in this study. 
From the three biological replicates, 206 protein kinases could be detected of which 163 were 
phosphorylated (Table I). On average, each kinase was identified by 19 tryptic peptides and 
at least two un-phosphorylated peptides were identified for 164 kinases. For phosphopeptides 
with more than one S/T/Y residues, the MaxQuant’s PTM scoring algorithm was used to 
calculate localization probabilities of phosphorylation sites for each of these residues [83]. 
Regarding the grouping of phosphorylation sites according to the confidence level of 
phosphorylation site identifications within the phosphopeptide sequences, we adapted the 
classification scheme of Olsen et al [57]. In total, 944 high-confidence phosphorylation sites 
on protein kinases were detected (class I sites), whereas 277 phosphorylation sites fell into 
lower confidence classes (class II and III sites). Kinase phosphopeptides accounted for 68% 
of the total phosphopeptide ion count, further demonstrating the efficiency of the kinase 
enrichment strategy. The use of SCX separation after in-solution digestion as an alternative 
strategy to SDS-PAGE (in combination with in-gel digestion) is beneficial, as only 34% of 
the total phosphorylation sites were identified by both methods, thus indicating that the two 
methods are highly complementary. However, we did not detect significant differences 
between the pools of phosphopeptides detected by the SCX and SDS-PAGE strategies s in 
terms of peptide length and the percentage of multiply phosphorylated peptides. To compare 
the kinase coverage of this work with the related prior studies of Daub et al.[83] and 
Dephoure et al. [86], we calculated the numbers and overlaps of the detected kinase 
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phosphorylation sites. Compared to the Daub et al. dataset we detected about the same 
number of kinase phosphorylation sites, whereas about 40 % more kinase phosphorylation 
sites were detected compared to the study by Dephoure et al., thus justifying the use of a 
kinase enrichment strategy. 
 
Table 1. Summary of the numbers of detected kinases and phosphorylation sites. 
 
2.5 Mitotic dynamics of kinase phosphorylation sites 
 SILAC triple labeling along with cell synchronization techniques allowed us to 
compare three specific mitotic stages. Phosphorylation site ratios were normalized to protein 
ratios in order to eliminate variations resulting from different expression levels at the 
analyzed stages, unequal sample mixing and labeling efficiency of different isotopic forms of 
arginine and lysine [45]. If no unphosphorylated peptides were detected to calculate protein 
ratios (7 % of the detected kinase phosphorylation sites), global correction factors were used 
[45] (appendix, suppl. Data S3). In order to choose optimal thresholds for identifying 
regulated phosphorylation sites, we analyzed a 1 to 1 mixture of mitotic lysates (identically 
prepared but distinctly SILAC labeled samples) in a separate experiment. Less than 95% and 
99% of the detected phosphorylation site ratios differed by more than 35% and 50%, 
respectively (appendix, suppl. Data S4). Based on these values, we decided to accept 
regulation levels above 1.5 (3/2) for upregulation and below 0.66 (2/3) for downregulation, as 
significant. Reproducibility of the results between the experiments was found to be high, 
even though the samples were biological replicates (suppl. Data S3). Less than 11 % and 19 
% of the phosphorylation site ratios differed from each other by more than 35% for 
prometaphase-metaphase and metaphase-telophase transitions, respectively, between 
experiment 2 and experiment 3 for example. Of the three replicates, experiment 3 was found 
to be best in terms of synchronization efficiency and number of detected phosphorylation 
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sites (Figure 8), so results from experiment 3 are shown in all figures unless otherwise 
mentioned. 
 
 During the prometaphase to metaphase transition, phosphorylation site regulation 
exceeding the above defined threshold was found to be confined to few kinases which 
comprise important known regulators of the SAC such as TTK (Mps1) and Plk1 (Figure 9A, 
Figure 10). Notably, even though the percentage of significantly regulated phosphorylation 
sites did not exceed 10 %, a stronger regulation of phosphorylated peptides compared to non-
phosphorylated peptides was observed (Figure 9B), thus demonstrating a small but significant 
regulation of the phospho-kinome between these mitotic stages. In contrast, a pronounced 
regulation of the phospho-kinome was observed in telophase with 17% downregulated and 
8% upregulated phosphorylation sites (Figure 9C). 
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Figure 8: Comparison of the biological replicate experiments in terms of synchronization 
efficiency (based on Cyclin B levels) and detected phosphorylation sites.  
A) Cyclin B levels along the analyzed mitotic stages as calculated by MaxQuant were plotted for the 
three experiments. The levels remained constant during prometaphase-metaphase transition whereas 
they dropped abruptly between metaphase and telophase, in complete agreement with Cdk1 activity. 
The extent of Cyclin B degradation is an indication of the synchronization efficiency in telophase. B) 
Number of class I kinase phosphorylation sites identified in each experiment.  
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Figure 9: Quantitative dynamics of the phosphokinome across mitosis.  
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A)Percentage of class I phosphorylation sites that are upregulated (upward directed bars) above a ratio 
of 1.5 or downregulated below a ratio of 0.66 (downward directed bars) between metaphase and 
prometaphase and telophase and metaphase, respectively. Percentage of the measured ratios between 
metaphase and Prometaphase  B), and between telophase and metaphase C) are depicted separately 
for phosphorylated kinase peptides (red) and unphosphorylated kinase peptides (blue). 
 
 Importantly, the identified phosphoproteins comprise key mitotic kinases, such as 
Cdk1, Plk1, Aurora A (AURKA), Aurora B (AURKB), and TTK (Mps1), allowing insight 
into their phosphorylation based regulation during mitosis (Figure 10). The activating 
phosphorylation site of the key mitotic kinase Cdk1, T161, for example, stayed constant in 
metaphase whereas the inhibitory phosphorylation site T14 continued to be dephosphorylated 
(Figure 10). Inactivation of Cdk1, which is required for mitotic exit, is reflected by the down 
regulation of the activating Cdk1 T-loop phosphorylation site T161 in the telophase sample. 
Plk1, another crucial mitotic kinase, contains two conserved threonines, T210 and T214, on 
its activation segment (Figure 10, Table II) which were both phosphorylated in mitosis. T210 
has been previously described as the major activating phosphorylation site of Plk1 in mitotic 
HeLa cells [21] and, in agreement with the essential role of Plk1 in cytokinesis, this site 
remained phosphorylated throughout mitosis. In contrast, T214 was found to be 
dephosphorylated after silencing of the spindle checkpoint in metaphase, suggesting that this 
phosphorylation site may have other functions than regulating Plk1 activity. During mitosis 
Aurora A is localized at spindle poles and the mitotic spindle, where it regulates the functions 
of centrosomes and spindles and is required for proper mitotic progression [32]. Aurora A 
activation segment phosphorylation sites (Figure 10, Table II) as well as 4 other 
phosphorylation sites of this kinase continued to be phosphorylated during the prometaphase-
metaphase transition, indicating that complete activation of Aurora A is not achieved until 
metaphase. Interestingly, the Aurora A activation segment was dephosphorylated in 
telophase, whereas phosphorylation of the Aurora B activation segment along with other 
phosphorylation sites, stayed constant in mitosis, which is in agreement with the reported role 
of Aurora B in cytokinesis.  
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Figure. 10: Phosphorylation dynamics of key mitotic kinases. 
The regulation of phosphorylation sites (red triangle: upregulated; green triangle: downregulated; blue 
square: regulation below threshold; black circle: no data available) is shown for the ratios between 
prometaphase and S-phase (first position, data taken from Daub et al.[83]), between metaphase and 
prometaphase (second position), and between telophase and  metaphase. Data were taken from 
experiment 3 (best synchronization) if available. Phosphorylation sites marked with a star were only 
detected in the experiments 1 or 2. 
 
  Maternal Embryonic Leucine Zipper Kinase (Melk) inhibits pre-mRNA splicing by 
binding NIPP1 in a cell-cycle regulated manner. In-vitro studies have shown that 
phosphorylation of T460, T466 and T478 residues is critical for Melk-Nipp1 binding [91]and 
pre-mRNA splicing inhibition. Importantly, our in-vivo data confirm these results as the 
phosphorylated Melk residues are highly dephosphorylated in telophase (suppl. Data S3). 
Similarly, PKC delta, which was recently shown to be important for meiotic spindle 
formation, was found to be dephosphorylated on multiple sites in metaphase [92] (suppl. Data 
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S3), suggesting that these phosphorylation sites may be interesting in the context of potential 
mitotic roles of this kinase.  
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Table 2.Dynamics of protein kinase activation segment phosphorylation.  
The regulation of kinase activation segment phosphorylation sites (red triangle: upregulated; green 
triangle: downregulated; blue square: regulation below threshold; black circle: no data available) is 
shown for the ratios between prometaphase and S-phase (first position, data taken from Daub et al. 
[83]), between metaphase and prometaphase (second position), and between telophase and metaphase 
(third position). Data were taken from experiment 3 (best synchronization) if available. 
Phosphorylation sites marked with a star were only detected in experiments 1 or 2. Non-Class I sites 
are underlined. 
 
2.6 Network analysis 
 Proteins work rarely in isolation but rather function in complexes as multi-protein 
machines. Importantly, members of protein interaction networks are frequently regulated in a 
similar fashion thus enhancing the robustness of signaling events [74]. To detect regulatory 
networks involved in mitotic exit, we therefore asked whether phosphoproteins with similar 
phosphorylation dynamics in telophase were enriched for members of specific interaction 
networks. To this end, we extracted a group of proteins containing at least one upregulated 
phosphorylation site (group U, 59 proteins) and another group, with proteins containing at 
least one downregulated phosphorylation event (group D, 130 proteins). Importantly, the 
overlap between the groups was modest (22 proteins), illustrating the specificity of the 
applied approach. To gain further insight into underlying mitotic phosphorylation networks, 
interaction network analyses were performed separately for the upregulated and 
downregulated groups and the results were visualized (appendix, Figure S1, S2). Strikingly, a 
Cdk1 interaction network was found enriched in group D (Figure 11A), which is in 
agreement with the de-activation of Cdk1 in late mitosis [93]. To compensate for the unequal 
number of proteins in each group, average numbers of interactors were computed (number of 
interactions in a particular group of proteins / total number of proteins in that group). 2.5 fold 
more Cdk1 interactors were found in D compared to U and 9 fold more, compared to a 
randomly chosen set of proteins (Figure 11B). Along similar lines, we observed that 54% of 
the phosphorylation sites matching a stringent Cdk1 motif ((S/T)PXR) were downregulated 
(suppl. Data S3), compared to the 17% of sites in the total dataset. This demonstrates that 
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although the overall number of downregulated phosphorylation sites is relatively small, a 
large number of Cdk1 phosphorylation sites are downregulated nevertheless.  
 
Figure 11: Interaction networks and enriched functional annotations.  
A) Selected part of an interaction network extracted from a group of proteins with downregulated 
phosphorylation sites centered on Cdk1; the insert B) shows the enrichment of Cdk1 interactors in the 
complete interaction network of proteins with downregulated phosphorylation sites (Fig. S5), 
compared to protein with upregulated phosphorylation sites (Fig. S6), and a random group from the 
Uniprot dataset. C) Highlights that the functional annotation term “microtubule skeleton” is enriched 
in this network. D) Selected part of an interaction network extracted from a group of proteins with 
upregulated phosphorylation sites in telophase, containing many MAP kinases. The insert E) shows 
the enrichment of MAPK interactors in the complete interaction network of proteins with upregulated 
phosphorylation sites (Fig. S6), compared to protein with downregulated phosphorylation sites (Fig. 
S5), and a random group from the Uniprot dataset. The enrichment of the functional annotation 
“nuclear membrane” in this network is shown in F). 
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 Regarding the group of proteins containing up-regulated phosphorylation sites,  
MAPK signaling pathway was found to be highly enriched (7.5 folds, p-value 1.4E-6) (Figure 
11D). Further, we analyzed the functional annotations of proteins in the D- and U-groups. As 
may be expected, ‘protein kinase’ and ‘cell cycle’ were highly enriched terms in both the 
groups. Apart from these, the term ‘microtubule cytoskeleton’ was enriched 4.8 fold (p-value 
1.4E-5) in D (Figure 11C). Interestingly, the enrichment of the term ‘nuclear membrane part’ 
in U (22.3 folds, P 6.3E-6) (Figure 11F) suggests that phosphorylation may also have a role 
in nuclear envelope reformation. 
 In summary, network analysis of sub-groups of proteins with similar phosphorylation 
dynamics identifies mitotic interaction networks of proteins and is therefore useful for the 
detection of the pathways targeted by phosphorylation-based signaling. 
 
2.7 MAPK pathways are activated during late mitosis 
 Although mitotic exit is thought to be mostly driven by dephosphorylation events, 
some kinases were nevertheless found to be phosphorylated in telophase. As shown above, 
functional annotation revealed that most of these kinases either belong to the MAPK family 
or represent components of MAPK pathways (Figure 11D). MAPKs have been studied 
extensively due to their strong association with many important cellular processes such as 
cell proliferation, survival, growth and differentiation [94]. As part of key signaling pathways 
MAPKs are activated in response to various mitogenic signals and stress factors. The role of 
MAPKs during the G1/S transition is relatively well understood but their function in mitotic 
progression has been discussed controversially. Initial studies suggested that Erk1 and Erk2 
localize to centrosomes and kinetochores and that their activities are required for proper 
spindle formation and timely metaphase-anaphase transition in mouse fibroblast like 3T3 
cells [95]. These finding, however, could not be confirmed by a successive study in normal 
and transformed human cells [96]. Another member of the MAP kinase family, p38 was 
observed to localize to centrosomes during HeLa cell mitosis [34] [97] and to be required for 
the metaphase-anaphase transition in developing retina [98]. However a subsequent study 
demonstrated that the timing of the metaphase-anaphase transition was not affected in 
absence of p38 activity [99]. Even though these conflicting results may be partially explained 
by the use of different model systems and experimental techniques, further elucidation of the 
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role of MAPK during mitotic progression is clearly needed. Since our study tracked the 
phosphorylation of kinases during mitosis through a kinome approach, a wide range of 
MAPK could be analyzed simultaneously (Figure 12A). We found that the MAP kinases 
Erk1/2 and p38 were phosphorylated on their activation segments and that the relative 
abundances of these phosphorylation sites peak during late mitosis (telophase). Importantly, 
these results were found consistently in all three biological replicates (appendix, suppl. Data 
S3) and were further confirmed using a phosphospecific antibody against the pTXpY motif of 
p38 and Erk1/2 with additional time points in mitosis (Figure 12B). MG132 treatment of cells 
is known to activate programmed cell death response that is initiated by Jnk activation, and 
p38 alpha is one of the prototypical stress-activated kinases. To address the concern that the 
observed pathway activation was related to drug related side effects, we released cells 
directly from nocadazole and still observed phosphorylation on p38 and Erk1/2, thus ruling 
out MG132 treatment as the primary cause of phosphorylation. To rule out nocadazole as the 
cause of phosphorylation we kept one batch of cells in nocodazole while another batch of 
cells was released from this drug. We observed phosphorylation on p38 as well as Erk1/2 
only in the cells that were released into telophase. 
 Taken together, we speculate that the detected upregulation of phosphorylation sites 
on a MAPK interaction network during late mitosis indicates a role of these kinases in late 
mitotic events, a view which is consistent with a recent report showing that phosphorylation 
of PKCε by p38 is required for cytokinesis [26]. 
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Figure 12: Activation segment phosphorylation of MAP kinases in mitosis. 
 A) Dynamics of activation segment phosphorylation of different MAP kinases identified in the study. 
B) Western blots depicting the activation segment phosphorylation of p38 & Erk1/2 MAP kinases. T- 
stands for thymidine blocked HeLa cells in S-phase. N- represents prometaphase sample obtained 
from nocodazole block. Upon release from nocodazole cells are harvested at 6 different time points. 
N* represents the sample for which the nocodazole block was continued for 150 minutes after the 
initial nocodazole block. Phosphorylation on p38 and Erk1/2 is observed only in the cells that were 
released into telophase. 
 
2.8 Changes made during mitotic entry are restored at the end of mitosis 
 Whereas the current study was focused on the dynamics of the phospho-kinome 
during different phases of mitotic progression, a previous study has quantitatively analyzed 
the phosphorylation of the kinome during S-phase and prometaphase [83]. Since one 
common time point (nocodazole block in prometaphase) was used in both experiments, it 
became possible to combine the results of the two studies to broaden the monitored time 
window and to analyze the correlation between the observed phospho-kinome dynamics 
(Figure 13).  
 Interestingly, phosphorylation sites which were found to be upregulated between S-
phase and prometaphase were significantly more downregulated between prometaphase and 
telophase than phosphorylation sites that either stayed constant during the prometaphase/S-
phase transition or were downregulated (Figure 13). This correlation is reminiscent of the 
cycling behavior of Cdk activities which drive the “cell cycle oscillator” [93; 100]. According 
to the current perception of mitosis, Cdk1 activity initiates mitosis and mitotic exit requires 
Cdk1 inactivation, thus restoring the initial state [101]. In line with this view, the observed 
correlation between upregulation during mitotic entry and downregulation at mitotic exit (and 
vice versa) can also be interpreted as a partial reconstitution of a “non-mitotic” 
phosphokinome state towards the end of mitosis.  
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Figure 13: Correlation between kinase phosphorylation site regulation at mitotic entry and 
mitotic exit.  
The proportions of the Class I kinase phosphorylation sites which were found upregulated (red), not 
significantly changed (blue) or downregulated (green) between S-phase and prometaphase (the ratios 
were taken from Daub et al.(35)) in relation to their regulation in telophase are shown. 
 
2.9 Regulation of non-kinases in mitosis 
 Even though a strong enrichment for kinases could be achieved through our 
experimental strategy (see above), other ‘contaminating’ proteins were also detected. These 
‘non-kinases’ may form stable complexes with kinases, as may be the case for the detected 
Cyclins, or bind to the kinase affinity columns through undesired selectivities [102]. Thus, a 
total of 1730 phosphorylation sites (Table I), including 1374 class-I sites could be identified 
on these proteins in addition to the above discussed kinase phosphorylation sites (suppl. Data 
S3) Although the detection of these other phosphorylation sites was not the purpose of this 
study, closer analysis revealed that key mitotic proteins were also covered, thus providing 
additional information on the regulation of mitotic progression dynamics. For instance, we 
identified more than 12 phosphorylation sites on Borealin, an important component of the 
Chromosomal Passenger Complex (CPC). Out of those, three of the conserved pTP sites, 
located close to the Borealin C-terminus, were consistently downregulated in telophase in all 
three replicates. During the metaphase to anaphase transition the CPC moves from 
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centromeres to the spindle midzone, which can be inhibited by constitutively active Cdk1 
[103]. Moreover, the C-terminus of Borealin was already previously shown to be important 
for CPC targeting to centromers [104]. It is therefore conceivable, that the three 
downregulated phosphorylation sites at the C-terminus of Borealin may play a role in 
targeting the CPC to centromers, so these sites may constitute attractive targets for future 
mutational analyses. Another detected phosphorylation substrate, Protein Regulator of 
Cytokinesis (Prc1), is a key protein required for cytokinesis and was found to be 
phosphorylated on 12 sites during mitosis. Previously, it was already reported that Plk1 
phosphorylates Prc1 at the two sites T578 and T602, thus promoting the interaction of Prc1 
with several kinesin motor proteins required for cytokinesis [105]. Interestingly, both these 
reported sites were identified in our study. Since the T602 containing peptide covers the C-
terminus of Prc1 and does not contain the SILAC labeled amino acids Lysine and Arginine, 
this peptide could unfortunately not be quantified. The peptide spanning the other reported 
phosphorylation site, T578, however, was found to be upregulated once all chromosomes 
were captured by microtubules (ratio 1.45 metaphase/prometaphase). Interestingly, also the 
protein level of PCR1 varied during mitosis, peaking in metaphase and decreasing again in 
telophase (ratios in experiments 1, 2 and 3: 1.3, 1.63, 1.88 metaphase/prometaphase; 1.22, 
0.62, 0.67 telophase/metaphase). As previous studies had suggested that the level of Prc1 
remains constant throughout mitosis [105], we speculate that the Prc1 level is maintained by 
an equilibrium between synthesis and degradation, so that MG132 mediated proteasome 
inhibition as used in this study, would result in elevated protein levels. It is also interesting in 
this context that, cap-independent protein translation during mitosis was shown to be 
important for recruiting Plk1 to the central spindle [106]. Since Prc1 plays a crucial role in 
targeting Plk1 to the central spindle, it may be rewarding to test whether Prc1 is translated 
through a cap-independent mechanism during mitosis.  
 In addition to the identification of potentially important regulatory phosphorylation 
sites, the detection of “non-kinase” proteins also allowed us to further evaluate 
synchronization efficiencies. The protein level of Cyclin B, the regulatory subunit of Cdk1, 
stayed constant between prometaphase and metaphase whereas it was found to drop 
significantly in telophase, a finding which is in agreement with western blot data (Figure 
14A) and the dynamics of mitotic Cdk1 activity. In particular, Cyclin B levels were found 
reduced by more than 3 fold, thus indicating that the synchronization efficiency of telophase 
cells exceeded 70 %. Further, the levels of α-Tubulin, a commonly used loading control for 
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mitotic samples, remained almost constant throughout mitosis (ratios in experiments 1, 2 and 
3: 0.98, 0.98, 1.07 metaphase/prometaphase; 0.92, 1.00, 1.00 telophase/metaphase) (Figure 
14B), highlighting the accuracy of SILAC based quantitation and downstream data analysis 
steps. 
 
Figure 14: Regulation of (A) Cdk’s and Cyclin’s and (B) Tubulins during mitotic progression were 
plotted for the three experiments. Except for Cyclin A, Cyclin B1, and Cyclin B2, levels of other 
Cyclins and Cdk’s remained almost constant throughout mitosis. Tubulin levels stayed very close to 1 
indicating the analytical accuracy the SILAC based quantitation. 
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Having demonstrated that value of a comprehensive phosphoproteomic approach for studying 
the regulation of mitotic progression in part 1 of this thesis, in the following part 2 I will 
describe my contribution to a collaborative study that focuses on the function of two key 
components of the mitotic spindle assembly check point, BubR1 and Bub1   
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3.0 Results (Part 2): Characterization of function of BubR1 and Bub1 kinase 
phosphorylation* 
*Part of this work is included in a manuscript that has been accepted for publication: Uncoupling of 
BubR1 Spindle Checkpoint and Chromosome Congression Functions. Sabine Elowe, Kalyan Dulla, 
Zhen Dou, Xiuling Li, Erich A. Nigg.Journal of Cell Science 123 (2010) 84-94. 
I emphasize that the work presented in this chapter was done in collaboration with Dr. Sabine 
Elowe (MPIB). The experiments described in 3.3 and 3.4 were performed by Dr. Elowe as 
well as generation of the Bub1 WT and KD constructs (in 3.6). The results are shown here in 
order to confer biological relevance to the proteomics analysis that was carried out by me. 
 
3.1 Introduction 
Budding uninhibited by benzimidazole 1 homolog beta (BubR1) protein, also known 
as mitotic-arrest deficient (Mad) 3 in yeast, derived its name from the loss of function study 
in which it was first identified [107]. Benzimidazole compounds such as nocodazole act as 
spindle poisons by destabilizing  microtubule structures. Contrary to  wild type cells, cells 
depleted of BubR1 fail to arrest in mitosis (metaphase) in presence of spindle poisons, 
leading to severe chromosomal defects. As described in (section 1.2.1), BubR1 is an essential 
component of the MCC, which is an integral part of the SAC that monitors spindle defects 
[2]. In yeast, the SAC is a non essential pathway which becomes important only in presence 
of spindle poisons or spindle defects. However, in metazoans, components of the SAC such 
as BubR1 are essential proteins, implying they have additional functions apart from SAC 
[108]. BubR1 is classified as a protein kinase due to its sequence homology, though 
substrates are not yet identified in-vivo and there is also no evidence for its kinase activity in 
in-vitro kinase assays. It was recently shown by our group that phosphorylation of BubR1 by 
Plk1 is required for stable kinetochore-microtubule attachments [87; 109]. Nevertheless, Plk1 
phosphorylation cannot alone account for the congression defects observed in BubR1-
depleted cells [110]. Indeed, in addition to Plk1, Cdk1 is able to efficiently phosphorylate 
BubR1 in-vitro [87]. We therefore sought to identify novel phosphorylation sites on BubR1 
that are specifically upregulated in mitosis and studied their functional significance. In 
addition, we also sought to study a closely related  kinase, budding uninhibited by 
benzimidazole 1 (Bub1), which is also an essential component of SAC signaling. Bub1 is 
highly phosphorylated in mitosis and localizes to kinetochores. It phosphorylates Cdc20, 
which regulates the binding of Cdc20 to MCC and thus  the activity of the APC/C (see 
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section 1.2.2) [111]. Similarly, there is also evidence for the involvement of Bub1 in other 
mitotic functions, though its precise role is poorly understood [2]. Like other kinases, Bub1 is 
also thought to be regulated by phosphorylation, hence information about the phosphorylation 
dynamics of Bub1 may provide valuable insight for functional studies.   
 
3.2 Identification of BubR1 phosphorylation sites in mitosis 
BubR1 is a low abundant protein, making its identification difficult without prior 
enrichment. To identify the BubR1 phosphorylation sites that are specifically regulated in 
mitosis we combined HeLa cell synchronization, antibody based BubR1 purification and 
SILAC quantitation. We performed two SILAC double labeling experiments (Figure 15). 
First, we compared phosphorylation and protein levels of BubR1 between S-phase and 
prometaphase. In a second experiment, comparison is made between prometaphase and 
metaphase (i.e. SAC active versus SAC inactive) (data not shown). Initial results showed that 
a large abundance of non-phosphorylated peptides masked the phosphorylated peptides, 
suggesting the need for a prior phosphopeptide enrichment step. Upon TiO2 based 
phosphopeptide enrichment we were able to indentify 12 phosphorylation sites (Figure 16a). 
This is a significant improvement compared to our whole kinome study where only two 
phosphorylation sites were identified on BubR1 (see part1) justifying the use of a small scale 
targeted approach. Out of many phosphorylation sites that were indentified on BubR1, 
phospho-Serine-Proline (SP) motifs (S543, S574, S670, S720, and S1043) were of particular  
interest, as SP motifs are preferentially phosphorylated by Cdk1, the “master-kinase” of 
mitotic  progression (Figure 16b). Using the SILAC approach, we were able to quantify the 
extent of mitosis-specific phosphorylation at 4 of these sites, and showed that 
phosphorylation is upregulated in the nocodazole arrested sample (Figure 17a). S574 was 
identified in a non-tryptic peptide; as it contained neither arginine nor lysine it could not be 
directly quantified by the SILAC procedure used here. Independently, Huang et al. recently 
reported the identification of S543, S670, and S1043 as mitosis specific phosphorylation sites 
on BubR1 [112], but S720 and S574 represent novel sites. 
 
  
Figure 15: Schematic representation of the SILAC double labeling procedure
Two populations of HeLa cells were grown in parallel in different SILAC media under identical 
conditions. One population of cells was snap frozen after 16 hour of thymidine block where as the 
second population of cells was washed and released into nocodazole c
and then snap frozen. In the second experiment   i.e. prometaphase vs metaphase, cells were blocked 
in nocodazole and mg132 respectively. Cells were lysed, mixed in a one to one ratio, and BubR1 
pulled down using an anti-BubR1 
from the antibody, separated on SDS
phosphopeptide enrichment.   
A) 
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ontaining media for 12
antibody. BubR1 (along with its interacting partners) was eluted 
-PAGE and analyzed by MS following trypsin digestion and 
 hours 
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Peptide Sequence Phosphorylation 
site 
Mascot 
Score 
Ratio 
(M/S) 
EGGALSEAMpSLEGDEWELSK S16 61 3 
YISWTEQNYPQGGK - 9 - 
ESNMpSTLLER S99 21 - 
LQpSQHR S191 25 5 
EAELLp(TS)AEKR T434 or S435 41 150 
pSPPADPPR S543 37 14 
TSESITSNEDVSPDVCDEFTGIEPLSED
AIITGFR 
- 21 0.5 
DLPpSDPER S633 20 3 
KLpSPIIEDSR S670 62 10 
LSPIIEDpSR S676 35 300 
EATHSSGFSGSSASVASTSSIK - 15 7 
LELTNETSENPTQpSPWCSQYR S720 58 24 
AEIVHGDLpSPR S884 51 85 
VQLDVFpTLSGFR T926 45 16 
VGKLTpSPGALLFQ- S1043 21 54 
 
                                                    B) 
 
Figure 16: List of BubR1 phosphorylation sites identified by mass spectrometry. 
A) The peptides identified in the study are listed along with the position of the phosphorylation site 
(phosphorylated serine, threonine and tyrosine residues are shown as pS, pT and pY), MASCOT score 
and the ratio between M-phase andS-phase. In cases where the position of the phosphorylation cannot 
be determined confidently, only the phosphopeptide sequence is shown. B) Sequence alignment of the 
five phosphorylation sites which are chosen for further study, indicating the common SP motif 
between these sites in BubR1. 
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3.3 Cdk1 phosphorylates S543, S670, and S1043 in-vitro 
To test whether the phosphorylation sites identified here contribute to the 
characteristic electrophoretic upshift of mitotic BubR1, MYC-tagged constructs for BubR1-
WT, -620A (Polo-box domain binding mutant), -5A, and the phospho-mimicking 5D (where 
all five phosphorylation sites were mutated to aspartate) were expressed in HeLa cells. The 
S620A mutant was included in this analysis, as we have previously shown that Plk1 
phosphorylation regulates the characteristic mitotic upshift in BubR1 [87]. Cells were then 
harvested after a 16 h released from thymidine arrest into nocodazole, before proteins were 
analyzed by Western blotting. BubR1-WT exhibited the characteristic double band pattern, 
whereas BubR1-620A, as predicted, migrated as a single faster migrating species (Figure 
17a). Both BubR1-5A and BubR1-5D also exhibited a double band pattern, suggesting that 
mutation of these 5 residues is not sufficient to eliminate the mitotic BubR1 upshift (Figure 
17a).  
Interestingly, the 5 sites described here comprise a serine followed by a proline 
residue, suggesting that a proline-directed kinase such as Cdk1 may phosphorylate these sites, 
although phosphorylation at several of these has been suggested to be Mps1-dependent [112]. 
To compare BubR1 phosphorylation by Cdk1 and Mps1, we performed in-vitro kinase assays 
using recombinant full-length BubR1 as a substrate. Whereas Cdk1 was able to efficiently 
phosphorylate BubR1, there was no detectable phosphorylation on BubR1 by Mps1 kinase 
representing the same specific activity (Figure 17b), although both Cdk1 and Mps1 
efficiently phosphorylated Borealin under the same conditions (Figure 17b). To clarify 
whether the SP sites identified here are indeed Cdk1 target sites, we generated 12mer 
peptides centered on each of the 5 serines and used these peptides as in-vitro substrates for 
Cdk1. Corresponding control peptides were synthesized with the serine phospho-acceptor 
positions changed to alanine to determine signal specificity. The peptides comprising S543, 
S670, and S1043 became phosphorylated in this assay, whereas the alanine versions of the 
same peptides were either not detectably phosphorylated or phosphorylated to a significantly 
reduced extent (Figure 17c). Collectively, these observations suggest that Cdk1 may directly 
phosphorylate BubR1 in-vivo, and that the loss of BubR1 phosphorylation upon Mps1 
depletion may reflect an indirect mechanism. 
 
  
Figure 17: Cdk1 phosphorylates BubR1 in
A) Western blot showing the electrophoretic mobility of MYC
phosphosite mutants BubR1-620A, 
control (lower panel). B) In vitro phosphorylation of recombinant MBP
Borealin (right panels) in either kinase buffer alone, or by Cdk1 or Mps1. BubR1 and Borealin input 
is illustrated by Coommassie brilliant blue (CBB) staining (lower panels). C) I
synthesized directly on cellulose membranes were used as substrates for Cdk1 in 
assays. Peptide phosphorylation was visualized by autoradiography.
 
3.4 BubR1-5A mutant expressing cells exhibit severe congression defects
Initially we sought to determine whether loss of BubR1 phosphorylation at the SP 
sites identified here results in changes to BubR1 localization or in gross structural defects in 
the protein. Endogenous BubR1 was depleted using siRNA oligos that target the 
region of BubR1 [87], and cells were simultaneously transfected with MYC
WT or phosphorylation site mutants. MYC
KT, as demonstrated by co-localization with Hec1, as did MYC
(data not shown). In addition BubR1
Cdc20 and Bub3 (data not shown), confirming that MCC assembly is maintained. These 
results demonstrate that mutation of the 5 phosphorylation sites on BubR1 did not result in 
gross conformation or structural defects in the BubR1 protein that would preclude 
kinetochore localization and MCC formation.
To explore whether the phosphorylation of the 5 identified SP sites on BubR1 
contributes to the congression or checkpoint function of B
independent approaches. Initially, we examined mitotic progression by staining of fixed cells 
(Figure 18a). After MG132 treatment, BubR1
A)                                             B)
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-vitro on S543, S670, and S1043:  
-tagged BubR1
-5A, and -5D (upper panel). Alpha-tubulin is shown as loading 
-BubR1 (left panels) or MBP
mmobilized peptides 
in
 
 
-tagged BubR1 
-BubR1 WT localized as expected to the outer
-BubR1 620A, 5A and 5D 
-5A and 5D retained the ability to co-immuno
 
ubR1 (or both), we took several 
-620A, -5A, and -5D-expressing cells were all 
                                                                    C) 
 
-WT and the 
-
-vitro kinase 
3’-UTR 
-
-precipitate 
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unable to align proper metaphases to the same extent as BubR1-WT expressing cells (Figure 
18b). This indicates that lack of phosphorylation on one or several of the 5 sites identified in 
this study causes congression defects, and that the BubR1-5D phospho-mimicking mutant 
cannot rescue the BubR1 depletion phenotype. A BubR1-4A/D mutant (which retained the 
previously described S670) also exhibited aberrant metaphases after MG132 treatment, 
arguing for a significant contribution from the remaining 4 serine residues to the chromosome 
alignment function of BubR1. 
Close examination of cells expressing the various mutants revealed differences with 
regard to their precise congression defects (Figure 18c). As expected, cells depleted of 
endogenous BubR1 and rescued with the empty plasmid failed to congress chromosomes 
efficiently, so that KTs were spread along the length of the pole-to-pole axis (Figure 18c). In 
contrast, cells expressing BubR1-WT generally formed tight metaphase plates, with KTs 
efficiently aligned at the spindle equator. Cells expressing BubR1-620A were largely able to 
align their KTs, although resulting metaphases were considerably broader, whereas both 
BubR1-5A and -5D expressing cells resembled those depleted of endogenous BubR1, with 
many KTs remaining unattached and spread along the entire pole-to-pole axis. Quantification 
of KT misalignment observed with the various BubR1 mutants revealed that the degree of  
misalignment in cells expressing either BubR1-5A or BubR1-5D was almost as severe as in 
cells entirely depleted of BubR1 (25% in BubR1-5A and 22% in BubR1-5D compared to 
30% of cells transfected with vector control (Figure 18c). These observations suggest that 
these 5 phosphorylation sites likely make the most significant contribution to the congression 
function of BubR1. As a second, complementary approach, we examined the function of 
BubR1 phosphorylation site mutants in real-time by time-lapse video microscopy performed 
on HeLa cells stably expressing histone H2B-GFP. To track individual cells, we used BubR1 
constructs tagged with mCherry, as previously described [87]. Representative stills from each 
movie, taken at the indicated time points after the onset of chromosome condensation, and 
quantification of time in mitosis is summarized in Figure 4d. Cells depleted of endogenous 
BubR1 and expressing the mCherry tag alone exited mitosis very rapidly (90% of the cells 
within 60 min), without metaphase alignment and often with lagging chromosomes, as 
expected. This phenotype was rescued by BubR1-WT expression. As previously described, 
BubR1-620A expressing cells exited mitosis more slowly, with approximately 40% of the 
cells entering anaphase more than 140 min after chromosome condensation, compared to 
about 25% of BubR1-WT expressing cells. Cells expressing BubR1-5A or BubR1-5D 
displayed severe congression defects; they were often unable to reach metaphase and many 
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cells were unable to exit mitosis within the imaging period (16 h). As a result, only 25% of 
BubR1-5A and 42% of BubR1-5D expressing cells reached anaphase within 140 min. 
Interestingly, amongst the cells expressing BubR1-5A and BubR1-5D that were able to exit 
mitosis, we were unable to detect any lagging chromosomes in anaphase. This, together with 
the observation that the many cells unable to align at metaphase did not exit mitosis, suggests 
that the checkpoint function of BubR1 is maintained in the BubR1-5A mutant. 
To more rigorously test this conclusion, we assessed the ability of cells expressing 
either MYC-BubR1 WT or BubR1 phosphosite mutants to remain mitotically arrested upon 
microtubule depolymerization. Non-rescued cells were unable to arrest in the presence of 
nocodazole, whereas cells rescued with BubR1-WT arrested efficiently (Figure 18e). 
Similarly, cells expressing MYC-BubR1-620A, -5A or -5D all arrested to the same extent as 
BubR1-WT expressing cells, indicating that the SAC function of BubR1 is functional in these 
cells. Collectively, our observations indicate that phosphorylation at the 5 sites described here 
is critical for BubR1 function in KT-MT attachment and chromosome congression, but is not 
required for mediating the SAC response in either an unperturbed mitosis or after a 
nocodazole challenge. 
 
 
A) 
 
B) 
 
D) 
C) 
E) 
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Figure 18: BubR1-5A mutants cause severe congression defects but retain SAC function. 
(A) Schematic representation of BubR1 rescue protocol for testing mitotic progression and 
chromosome alignment. B) Representative images of metaphase cells expressing the various BubR1 
phosphomutants after 3 h MG132 treatment. Cells were co-stained for alpha-tubulin (Cy2, shown in 
green), CREST human autoimmune serum (Cy5, shown here in red), and MYC (Cy3, shown in red) 
to facilitate identification of rescued cells. Representative KT-MT connections (white arrows) were 
enlarged and are shown below each image. Scale bar represents 10µm. C) Quantitation of the degree 
of chromosome misalignment in cells expressing BubR1 mutants in (B). KT position was measured as 
a function of the distance from pole-spindle equator. Bars represent the mean ± SE of 5-6 cells, > 60 
KTs per cell. E) Bar graph indicating time elapsed between chromosome condensation and anaphase 
onset. Elapsed time was split into three categories: 0-60 min, 60-140 min, and >140 min, and the 
percentage of cells fitting into each category was calculated for cells expressing each of the different 
MYC-BubR1 constructs. Bars are represent the mean ± SE of 8 independent experiments (n=100-220 
cells). F) Bar graph showing mitotic index (after 14 h nocodazole treatment) in cells depleted of 
endogenous BubR1, and expressing BubR1 phosphorylation site mutants relative to BubR1-WT 
expressing cells. Bars indicate mean ± SE of 3 independent experiments (160-250 cells per 
experiment). The mitotic index of non-treated cell analyzed under the same conditions was 27%. 
 
3.5 Bub1 phosphorylation in mitosis 
With the encouraging results from the functional studies of BubR1 phosphorylation we next 
sought to also study phospho-regulation of Bub1 kinase. Little is known about the function of 
Bub1 mitotic phosphorylation. From the whole kinome study we identified four 
phosphorylation sites on Bub1 (Figure 19). Furthermore, a few additional sites were also 
reported on Bub1 in the Uniprot database.   
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Modified Sequence Phosphorylated 
Residue 
Mascot Score Ratio 
(Meta/Prometa) 
MGPSVGpSQQELR S331 25 0.3 
VQPSPTVHTK - 14 1 
TLAPSpPK T593 10 1 
SpPGDFTSAAQLASTPFHK S596 28 0.8 
DGKFSpPIQEK S655 35 1 
 
Figure 19:Bub1 in-vivo phosphorylation sites identified in whole kinome study. 
The Bub1phosphopeptides identified in the whole kinome study are listed along with the position of 
the phosphorylation site (phosphorylated serine, threonine and tyrosine residues are shown as pS, pT 
and pY), MASCOT score and the ratio between metaphase and prometaphase. In cases where the 
position of the phosphorylation cannot be determined confidently, only the phosphopeptide sequence 
is shown. 
 
3.6 Increasing the sequence coverage of Bub1 by using multiple proteases 
In proteomics, trypsin is the protease of choice for generating peptides from proteins. 
However, digestion by trypsin alone does usually not lead to allow complete sequence 
coverage of the protein, since many resulting peptides may be too short or too long for 
sensitive detection by MS. We therefore employed the additional proteases Lys-C, Glu-C 
(V8) and Elastase in our workflow and found that the use of multiple proteases increased the 
sequence coverage of  Bub1 by two fold (Figure 20).   
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Figure 20: Sequence coverage of Bub1 obtained with multiple proteases. 
Employing multiple proteases increased the sequence coverage of Bub1 from 33% (trypsin alone) to 
68% (trypsin, elastase and glu-C). Peptides identified by combination of proteases is shown in bold 
and red whereas peptides identified with trypsin are underlined. 
 
3.7 Identification of auto-phosphorylation sites on Bub1 
Bub1 is a multi-tasking kinase required for the SAC and for proper segregation of 
chromosomes during mitosis. Unlike BubR1, Bub1 was shown to contain active kinase 
domain in-vitro and some in-vivo substrates have also been reported [113]. One of the 
common mechanisms of regulation of kinase activity is through T-loop phosphorylation 
and/or autophosphorylation. Therefore, identification of Bub1 autophosphorylation sites can 
throw light on phospho-regulation of Bub1. To identify autophosphorylation sites, we 
combined SILAC based quantitative Mass spectrometry, antibody based Bub1 purification 
and in-vitro kinase assays. 
We expressed Bub1 wild type (WT) and kinase dead (KD) versions in 293T cells 
(Figure 21). Mitotic cells were lysed and Bub1 was purified by immpunoprecipitation. Bub1 
WT and KD were subjected to kinase assays separately, allowing autophosphorylation to 
occur. Next, phosphorylation of Bub1 and its interacting partners was quantitatively 
compared between WT  and KD using SILAC. To address the reproducibility, experiments 
were carried out in biological triplicates. (Figure 23). We observed around 15 
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phosphorylation sites which were highly upregulated in kinase assays using the WT 
enzyme.(Figure 22, Figure 23). Results were consistent between the triplicate experiments.   
 
 
 
Figure 21: Schematic representation of workflow for the identification of in-vitro Bub1 
autophosphorylation sites 
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Peptide Sequence Residue Score Ratio WT/KD 
APCLPVTYQQTPVNMEK - 7 100 
CNKpTLAPSPK T589 29 66 
DGKFpSPIQEK S655 33 2 
EAPPVVPPLANAISAA-
LVSPATSQSIAPPVPLK 
- 18 4 
FpSPIQEKpSPK S655 & S661 15 2 
FSPIQEKpSPK S661 19 3.4 
GESEFSFEELR S247 46 0.8 
GpTIFTAK T960 38 56 
GpTIFpTAK T960 & T963 12 10 
IISSLSSAFHVFEDGNK - 44 61 
LHQVVETSHEDLPApSQER S314 32 1 
LLpSGLSK S752 14 34 
LPpSKPK S563 17 9 
LPVEpSVHILEDK S618 52 6 
LpSQPAAGGVLTCEAELGVEACR S679 56 11 
LpTETHLPAQAR T148 18 4 
MGPSVGpSQQELR S331 44 1.3 
NKPpTGAR T548 11 100 
NQGSELSGVIp(SS)ACDK S198 or S199 67 49 
QALSSHMYSASLLR - 72 28 
QCTQATLDSCEENMVVPSR - 45 1.4 
RVITISK T213 23 100 
SEYSVHSSLASK - 46 8 
pSNPGNNMACISK S176 53 47 
pSPGDFTSAAQLASTPFHK S596 95 2 
P(SS)GAWGVNK S509 or S 510 60 48 
TEFQLGSK - 13 5 
pTFGER T552 22 9 
pTLAPSPK T589 26 49 
TSEPLHNVQVLNQMITSK - 63 43 
VANTSSFHTTPNTSLGMVQATPSK - 30 44 
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VITISKSEYSVHSSLASK - 36 10 
VQPpSPTVHTK S459 17 1.4 
AQTVTDSMFAVApSK S402 53 61 
    
Figure 22: Bub1 auto-phosphorylation analysis. 
List of phosphorylation sites identified on Bub1 upon in-vitro kinase assay. Bub1 sites phosphorylated 
by kinases other than Bub1 should be of the same abundance between WT and KD samples. 
Phosphorylation sites that are highly phosphorylated only in the WT (i.e. high WT/KD ratio) are most 
likely reflecting autophosphorylation. 
 
 
 
Figure 23: Results from the three Bub1 auto-phosphorylation experiments were well in 
agreement with each other 
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3.8 Identification of phosphorylation sites on Bub1 interaction partners 
During the co-immunoprecipitation the Bub1 interaction partners BubR1 and Bub3 
were also enriched in the Bub1 preparation. Phosphopeptide analysis showed that both BuR1 
and Bub3 contained phosphorylation sites which were upregulared upon Bub1 kinase assay, 
indicating these sites might be phosphorylated by Bub1 (Figure 24). However, it is important 
to note that BubR1 and Bub3 phosphorylation sites could be identified only in one 
experiment each (presumably due to their low abundance in Bub1 immunoprecipitates). 
Hence further studies would be required to confirm the reality of Bub1 phosphorylation sites 
on BubR1and Bub3. 
 
 
Protein Peptide Residue Score Ratio Wt/KD 
BubR1 DLPpSDPER S633 15 0.5 
BubR1 IEPSINHILSTR - 18 7.031 
BubR1 LQpSQHR S191 17 18.544 
BubR1 VQpSHQQASEEK S384 23 21.339 
BubR1 STLAELKpSK S232 15 35.493 
Bub3 VAVEYLDPpSPEVQK S211 28 1.26 
Bub3 TGSNEFK - 8 1.34 
Figure 24: BubR1 and Bub3 phosphorylation upon Bub1 kinase assay. 
List of phosphorylation sites identified on BubR1 and Bub3 upon Bub1 in-vitro kinase assay. BubR1 
and Bub3 sites phosphorylated by kinases other than Bub1 should be of similarabundance between 
WT and KD samples; hence, the phosphorylation sites that are highly phosphorylated only in WT 
enzyme (i.e. high WT/KD ratio) are most likely phosphorylated by Bub1. 
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4.0 Discussion 
 
4.1 Small-molecule kinase inhibitor based enrichment of the kinome 
By using large amounts of starting material and a combination of approaches, we have 
identified more than 900 unique phosphorylation sites on protein kinases, including novel 
sites, illustrating the complexity of the mitotic kinome signalling network. Prior enrichment 
of the kinases using inhibitor based affinity chromatography was found to be the key to 
increase the coverage of the kinome. The strategies presented here for studying phospho 
kinome are not specific to mitosis and in principle can be applied to any comparative 
proteomic study focused on  the regulation of the kinome. For instance, Schreiber et al. 
studied Lysophosphatidic acid (LPA) induced signaling events in A498 kidney carcinoma 
cells using both total cell lysates and protein kinase-enriched fractions. This integrated 
workflow allowed extensive coverage of LPA signaling by capturing both kinases and their 
substrates[114]. Similarly, Sharma et al were able to identify and quantify  cellular target 
protein interactions with externally introduced ligands using a kinase inhibitors based 
enrichment strategy [115]. 
To get a good coverage of the mitotic phosphokinome, we used 60mg of protein from 
each cell cycle stage. However, for many applications obtaining such a large amount of 
starting material would be a difficult task. Moreover, in many cases quantitating the kinome 
itself, across different cell types or physiological states, can provide valuable insights. Such 
small scale studies or the studies focusing on protein levels, can still benefit from using just 
one inhibitor (VI16832) alone as immobilized kinase capturing ligand (our study used four 
additional capturing ligands along with VI16832). This simplified workflow provides 
enrichment for more than 150 kinases from 1 mg of starting material [102]. 
Although we identified more than 200 kinases in our present study, these represent 
only 40% of the human kinome. However this can be explained considering that not all 
kinases are ubiquitously expressed; many kinases are specific to a particular tissue or 
physiological state. This is exemplified in the recent study by Oppermann et al who 
compared kinomes of three different cell lines and observed that expressed kinome greatly 
vary among different cell types [102]. Moreover many members of the kinase superfamily 
share high sequence homology. In bottom up proteomics, proteins are digested into peptides 
and the peptides capable of discriminating the isoforms (unique peptides) may not be suitable 
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for analysis in MS due to their size, sequence or PTMs. This problem is even more 
pronounced in shotgun proteomics where frequently only few peptides are identified for the 
proteins. For instance, the peptides indentified in our study map to 292 kinases but only 190 
of them contained unique peptides. 
 
4.2 HeLa cell synchronization 
Interestingly, in spite of the complex nature of events involved, eukaryotic mitosis 
lasts less than one hour. Quantitation of phosphorylation/protein levels across mitosis poses a 
challenge as mitotic stages are difficult to synchronize due to their close spacing in time. 
Efficiency of cell synchronization is a critical factor that decides the minimum measurable 
change in phosphorylation/protein levels. For instance, in a hypothetical scenario where a 
phosphorylation site is regulated fourfold between two stages, when studied in a sample of 
50% purity, only 2 fold regulation is observed. Hence, we addressed this situation by 
optimizing the cell synchronization methods to improve purity of the sample and conducting 
the experiments in biological triplicates. 
Cell permeable inhibitors targeting various proteins involved in cell cycle progression 
serve as valuable tools for basic research.  Although thymidine and nocodazole blocks do not 
exactly mimic physiological stages of the cell cycle, both have been shown to fairly 
reproduce cell cycle events and helpin understanding cell cycle regulation. This is 
exemplified by the vast amount of scientific literature citing these reagents. However, some 
concerns still remain- for example, it cannot be ruled out that some of the observed changes 
may be the result of mild activation of the DNA damage and/or response apoptosis induced 
by  thymidine and nocodazole blocks, respectively. In the event of DNA damage, key mitotic 
kinases such as Cdk1 and Plk1 are inactivated, preventing cell entry into mitosis. In our 
synchronization procedure more than 90% of the cells entered mitosis, arguing against DNA 
damage response activation. Further, in case of MAP kinase phosphorylation, which is 
examined using additional experiments (Figure 12), similar results were obtained even in the 
absence of MG132 or during prolonged nocodazole block. So it is more probable that the 
observed phospho-regulation is specific to each mitotic stage and not related to drug induced 
side effects. 
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Growing HeLa cells in suspension cultures has many advantages over growing them 
on plates. Studies requiring large amounts of material would be laborious and costly if done 
on cell culture plates. Suspension cultures achieve high cell densities (1.2-1.8 X 106 cells/ml), 
minimizing the usage of cell culture medium usage and other reagents. This would be an 
important consideration if the medium is supplemented with expensive reagents such as 
isotopic amino acids, inhibitors etc. Typical HeLa S3 cells form cell aggregates after few 
generations in suspension cultures. To overcome this problem we used a non adherent variant 
of the HeLa S3 cell line, known as HeLa S. Additionally, comparisons of results with  Daub 
et al [83] and Dephoure et al [86] as well as further studies carried out in our laboratory 
shown that the results obtained in these two cell lines are similar (data not shown). 
The protocols for large scale synchronization of cells in mitosis are useful in isolating 
many other sub-proteomes such as the mitotic spindle. As an example, isolation of mitotic 
spindles also requires large amounts of starting material and spinner cultures are found 
unsuitable due to high percentage of interphase cells, making their purification laborious 
[116].  Since in our method we were able to minimize the interphase cells in the mitotic 
preparation, we tried isolating the spindles from spinner cultures and obtained good results. 
These strategies thus respond to a growing contemporary need for comparative studies of 
different sub proteomes. 
 
4.3 Identification of protein kinases 
After extensive analysis of the human genome and EST databases, Manning et al 
narrowed down the human kinome to 518 putative members and provided their sequences 
[15]. However sequence databases such as IPI, NCBI, Swissprot etc. contained several 
additional sequences (redundant entries, splice variants) with different names. As mentioned 
in the above section, in bottom-up proteomic studies proteins are digested prior to 
measurement by MS and thus protein sequences are inferred by matching the peptide 
sequences to the protein sequence database. This is a non trivial step as the peptide sequence 
may match to multiple protein sequences, especially to  different splice variants [89]. 
Whenever the set of identified peptides in one protein was equal to or completely contained 
in the set of identified peptides of another protein, these two proteins were joined in a single 
protein group and the protein with maximum number of peptides is shown as the leading 
protein for that protein group.  However, most of the 944 protein kinase phosphorylation sites 
identified in our study matched to more than one protein sequence in the IPI database (suppl. 
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Data S3). Furthermore, in some cases identified peptides in both proteins were  identical, 
meaning that leading protein assignment was arbitrary. This created a problem for counting 
the number of protein kinases, comparison of phosphorylation sites between different studies 
and also while using bioinformatic tools such as DAVID. We dealt with this problem by 
stripping off the protein information from the phosphopeptide sequence and using this 
sequence for comparing with kinase sequences provided by Manning et al and also for 
comparisons with datasets from Daub et al [83] and Dephoure et al [86]. This approach has 
the advantages that we were able to match the peptide/phosphorylation sites between 
different datasets even if they corresponded to different names of a same protein. However, 
the caveat remains that in some minority cases two different proteins (with different 
functions) may generate an identical peptide sequence and assigning the peptide to the wrong 
protein can give rise to artifacts in comparison between different datasets as well as in the 
downstream GO, pathway and PPI analysis. 
 
4.4 Global view of mitotic kinome 
Traditionally, the study of protein phosphorylation was a difficult task; new 
phosphorylation sites were indentified using mutational analyses and their regulation studied 
using phospho-specific antibodies. As a result, protein phosphorylation was often studies in 
isolation or using few controls. However, the situation changed with the introduction of MS 
and the advances in phosphoproteomics. MS based phosphorylation analysis allows the study 
of multiple proteins simultaneously, thus generating a global view of the system that is being 
studied. The main advantage of our data is that we were able to quantitatively measure the 
dynamics of site-specific phosphorylation as well as protein levels from a single sample. 
Kinases and their substrates form complex signaling networks where the status of each node 
depends on the status of other nodes in that network. As an example, the activity of the 
mitotic master kinase Cdk1 is controlled in a coordinated manner. Phosphorylation on the T-
loop activates the kinase, whereas phosphorylation in the N-terminus inactivates it. Cdk1 
inactivating kinases (Wee1, Myt1) as well as activating(Cdc25) phosphatases are also 
controlled by Cdk1 by feedback loops. The activity of Cdk1 is further modulated by its cyclin 
binding partner, which stabilizes T-loop phosphorylation and confers substrate specificity. In 
such a complex network, looking for a particular phosphorylation state or protein will not 
give the real picture. Especially while studying a disease state, such as tumor cells which 
have undergone adoption in response to their environment, comprehensive coverage of the 
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system is essential. As a result the ability to measure the regulation of a particular protein in 
comparison to the status of other proteins is of utmost importance. The large number of 
identified kinase phosphorylation sites (and also their interacting partners) enables an 
unbiased and quantitative view of the regulation of kinase networks, and thus constitutes a 
valuable tool to study the systems properties of the kinome during mitosis. It is a well 
established fact that Cdk1is made inactive at the end of mitosis. We could see this 
phenomenon in our data at multiple levels. The levels of the Cdk1 subunit cyclin B went 
down in telophase samples, together with T-loop dephosphorylation on Cdk1. Further 
network analysis of jointly regulated protein groups suggested that the Cdk1  centered 
interaction network is downregulated in late mitosis (Figure 11 a,b). Similarly we found that 
Erk1/2, p38 MAP kinases are activated late in mitosis (Figure 11 d,e). This novel finding is 
further strengthened by the observation that members of MAP kinase pathways are enriched 
in proteins with upregulated phosphorylation sites in telophase.  
The above discussion clearly illustrates the power of a comprehensive kinome 
analysis. As described in the first part of this thesis, the analysis of phosphorylation sites on a 
protein population enriched for protein kinases has provided a wealth of information on the 
regulation of mitotic progression. However it would be unrealistic to expect that a 
comprehensive analysis of the type discussed above could provide complete coverage or 
detailed information on the phosphorylation events on any particular mitotic kinase. Hence, it 
is indispensable to complement comprehensive approaches with focused approaches, as 
detailed in part 2 of this thesis and discussed below with regard to our results on BubR1 and 
Bub1 
 
4.5 Regulation of BubR1 function by phosphorylation 
We reported here the identification of 5 proline-directed phosphorylation sites on 
BubR1 and shown that at least 3 of the 5 sites are direct targets of Cdk1 in-vitro. Further we 
have showed that loss of BubR1 phosphorylation results in faulty KT-MT attachments and 
poor chromosome congression. In contrast, phosphorylation, at least at the sites described 
here, appears to be largely dispensable for the SAC functions of BubR1. Huang et al. recently 
suggested that Mps1 may be a major kinase for BubR1 in-vivo [112]. Although we also 
observe loss of BubR1 phosphorylation upon Mps1 inhibition (data not shown), we have 
been unable to directly phosphorylate BubR1 by Mps1 and thus favor the view that the 
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reported result may represent an indirect effect, perhaps reflecting mislocalization of BubR1. 
Indeed, a mislocalization of endogenous BubR1 upon Mps1 inhibition (our unpublished 
results), and the lack of any detectable phosphorylation on the mislocalized BubR1-E413K 
mutant support the conclusion that KT localization of BubR1 is required for its 
phosphorylation. Importantly, the finding that phosphorylation on BubR1 at one of these SP 
sites, S670, is significantly enhanced at unattached KTs but not at KTs lacking tension 
(appendix), is in excellent agreement with the above study [112]. Recent studies indicate that 
Cdk1-cyclin B1 localizes to KTs during prometaphase, where it contributes to the correct 
attachment of MTs to KTs and efficient chromosome alignment through phosphorylation of 
local substrates [117; 118]. Moreover, KT recruitment of Cdk1 is increased in nocodazole but 
not taxol treated cells [117], in agreement with the increase in S670 phosphorylation 
observed here upon nocodazole but not taxol treatment. 
 
4.6 Regulation of SAC and chromosome congression by different motifs of BubR1 
BubR1 is a checkpoint protein which performs multiple functions in mitosis. In our 
present study, we carried out functional analysis of conserved motifs of human BubR1 and 
demonstrated that SAC and chromosome attachment functions can be uncoupled from each 
other. Mutation of five proline-directed serine phosphorylation sites identified in vivo by 
mass spectrometry abolished chromosome-spindle attachments but had  no effect on SAC 
functionality. In contrast, mutation of the two conserved KEN boxes required for SAC 
function did  not impact on chromosome congression [119]. Interestingly, the contribution of 
the two KEN box motifs was found to be not equal. Cdc20 associated with the N-terminal but 
not the C-terminal KEN-box, and mutation of the N-terminal KEN motif resulted in more 
severe acceleration of mitotic timing. Moreover, the two KEN motifs were not sufficient for 
maximal binding of Cdc20 and APC/C, which also requires sequences in the BubR1 C-
terminus. Finally, mutation of the GLEBS motif caused loss of Bub3 interaction and 
mislocalization of BubR1 from the kinetochore; concomitantly, BubR1 phosphorylation as 
well as SAC activity and chromosome congression were impaired, indicating that the GLEBS 
motif is strictly required for both major functions of human BubR1[119].  
 
4.7 Autophosphorylation and substrates of Bub1 kinase 
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We have combined quantitative mass spectrometry and phosphopeptide enrichment 
with traditional in-vitro kinase assays to identify site-specific autophosphorylation on Bub1 
and its substrates. Contrary to BubR1, Bub1 kinase activity is well established and required 
for multiple mitotic functions. Kawashima et al shown that phosphorylation of yeast histone 
2A by Bub1 prevents chromosomal instability by insuring centromeric localization of 
shugoshin [113]. Similarly, Gao et al reported that Bub1 phosphorylates p53 (at serine 37) 
upon SAC activation. This delays p53 mediated cell death and provides time for cells reach 
chromosome biorientation [120]. In spite of these efforts many substrates of Bub1 still remain 
elusive. Eukaryotic cells have high kinase activity; as a result, differentiating phosphorylation 
sites by a  kinase of interest against a huge pool of phosphorylation sites targeted by  other 
kinase poses a big challenge. Further, the coverage of the phospho-proteome obtained in 
typical proteomic studies is far from complete and mostly confined to abundant proteins. In 
our experience, many of the important mitotic proteins (including the known interactors of 
Bub1) are difficult to identify in MS without prior enrichment. To counteract some of these 
problems we devised an Affinity purification MS (AP-MS) method. In these expirements, 
Bub1 was pulled down from cell lysates along with its interacting partners, using a Bub1-
derived monoclonal antibody. Then, in-vitro kinase assays were performed using the same 
endogenous Bub1 kinase. This setup allowed us to identify both autophosphorylation on 
Bub1 and Bub1 phosphorylation sites on its interacting partners.  
We identified more than 24 phosphorylation sites on Bub1. Out of those sites 15 were 
phosphorylated more than two fold compared to a Bub1 kinase dead mutant meaning that 
these sites are most likely phosphorylated by Bub1 (autophosphorylation). Moreover we 
achieved 67% of Bub1 sequence coverage compared to 16% in the large scale kinome study. 
We also identified 3 sites on BubR1 which are highly phosphorylated in presence of Bub1. 
Taken together this shows that our strategy was successful in identifying Bub1 
autophosphorylation sites.  
Interesting, we could also identify phosphorylation sites on BubR1 (a Bub1 interactor) 
that  were highly phosphorylated Bub1 kinase assays, suggesting  that they are likely to be 
phosphorylated by Bub1 in-vivo also. In contrast,  the phosphorylation sites identified on 
Bub3 within the Bub1 immunoprecipitates stayed constant, indicating that they are most 
likely phosporylated another kinase. Interestingly,  of the two phosphorylation sites 
indentified in Bub3, S211 is highly conserved among different species (data not shown). 
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Since little is known about Bub3 phosphorylation I might be rewarding to explore the 
function of S211.    
 
4.8 Advances in MS instrumentation and data analysis tools make large scale proteomic 
studies possible 
In the current report we presented results from three sets of experiments aimed at 
understanding the phospho-regulation of kinases.  First, a large scale whole kinome study 
which captured known key mitotic kinases such as Plk1, TTK (Mps1), Aurora A, and Aurora 
B as well as many kinases which have not previously been implied in mitotic functions. Thus, 
the results of this study recapitulate many of the previously known mitotic events but also 
identify attractive candidates for future studies of phosphorylation-based mitotic signaling. 
Second, a small scale targeted study showed that the chromosome congression function of 
BubR1 is mediated through five proline-directed phosphorylation sites. And third, a further 
small scale targeted study investigated regulation of Bub1 by autophosphorylation and in 
addition identified candidate Bub1 phosphorylation sites on its interactors. In all these 
studies,  we combined advances in mass spectrometry with biochemistry and cell biology 
techniques. The orbitrap MS, which became commercially available around the time this 
project was initiated, helped immensely in both identifying the phosphorylation sites and 
quantifying their regulation across different states. Phosphopeptides often have low signal-to-
noise  ratio and do not fragment well in MS/MS. However, the high mass accuracy and 
resolution of orbitraps (<7 ppm, 60,000 FWHM) reduce false positive identifications 
allowing identification of peptides with low Mascot scores. Further, this also helped during 
SILAC based quantitation; high mass accuracy and resolution helps to precisely locate the 
SILAC pair and distinguishes true signal from noise[121].Reduced false positive rates also 
benefit quantitation accuracy as SILAC ratios of wrongly identified peptides may differ from 
the ratios of true peptides, thus shifting the mean ratio. 
On an  concluding note, as the proteomic studies are becoming larger and larger, with 
multiple replicates and thousands of protein/peptide identifications, data analysis is becoming 
the major bottleneck. For instance, we used two different software suits; MSQuant (BubR1 
and Bub1 studies) and MaxQuant (whole kinome study) for SILAC data analysis. Although, 
MSQuant, one the popular open source programs, offered flexibility and supported multiple 
workflows, became very difficult to scale up when the number of identifications and raw files 
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increased.. In contrast,  MaxQuant, a recently introduced freely available program, is fully 
automated with minimal user intervention. It cuts down the analysis time for of around 150 
raw files and half a million MS/MS spectra to just a few days. Thus programs such as 
MaxQuant are indispensible for large scale proteomic studies. 
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5.0 Experimental procedures: 
5.1 Antibodies  
Anti-pSer676 BubR1 was raised in-house [87], anti-pThr180/Tyr182 p38 (#9211); anti-p38 
(#9212); anti-pThr173/Tyr175 Erk1/2 (#4376); anti-Erk1/2 (#9102) were from Cell Signaling 
Technologies, anti-pSer10 HistoneH3 (#06570) and anti-Cyclin-B (#05373) were from 
Upstate, anti-Securin (#ab3305) was from Abcam, and anti-α-Tubulin (#T9026), anti-α-
Tubulin−FITC (#F2168) were from Sigma-Aldrich, anti-MYC (9E10, ATCC), anti-Bub1 
(Chemicon), CREST anti-human auto-immune serum (Immunovision).   
 
5.2 Cell Culture, SILAC labeling and synchronization  
For SILAC, HeLa S cells were grown in DMEM containing 10% dialyzed FCS (PAA), 50 
U/ml penicillin, 50 µg/ml streptomycin and unlabeled L-arginine (R0) and L-lysine (K0) 
(Sigma) (SILAC light) or L-[U-13C6,14N4]arginine (R6) and L-[2H4]lysine (K4) (SILAC 
medium) or L-[U-13C6,15N4]arginine (R10) and L-[U-13C6,15N2]lysine (K8) (SILAC 
heavy) (Cambridge Isotope Laboratories). Cells were grown at 37 °C in a humidified 
incubator with 5% CO2 atmosphere. After five cell doublings on culture dishes, cell cultures 
were expanded in spinner flasks (INTEGRA Biosciences). Spinner flasks were operated at 45 
rpm and were kept inside the cell culture incubator. Prior to synchronization, cells were 
transferred to 400 ml fresh medium with 20% FCS and the cell density was adjusted to 0.6 x 
106 cells/ml. HeLa S cells were first synchronized at the G1/S phase boundary by treatment 
with 4 mM thymidine (Sigma) for 16 h. They were then released for 12 h into fresh medium. 
After 4 h of release, 40 ng/ml nocodazole (Sigma) was added to arrest the cells in 
prometaphase. One population of the prometaphase arrested cells was harvested by 
centrifugation, whereas the two other populations were washed once, centrifuged at 300 x g 
in PBS, and released in fresh medium containing 20 µM of MG132 (Calbiochem) to induce 
metaphase arrest. The population of metaphase arrested cells was then harvested by 
centrifugation, whereas the last population of cells was washed and released in fresh medium 
for 90 min, when most of them had reached telophase. Harvested cells were snap-frozen by 
liquid nitrogen and stored at −80°C until cell lysis. For BubR1 and Bub1 studies, cells were 
grown essentially as described above but only using SILAC light and heavy media. These 
experiments were performed using 15-25 million cells per each stage. 
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5.3 Immunofluorescence staining of cells  
Before harvesting the cells at different mitotic stages, a small aliquot of around 0.5 ml of cell 
suspension was taken into a 1.5 ml tube and incubated with fixing solution (1% 
paraformaldehyde and 3% sucrose). Approximately 10% of the fixed cells were transferred to 
a fresh 1.5 ml tube, treated with Triton X-100 (final concentration 0.1%) at room temperature 
for 15 min with constant shaking. Cells were then centrifuged at 300 g and the supernatant 
was discarded. The cell pellet was resuspended in 100 µl of PBS with 2% BSA. DAPI and 
anti-α-Tubulin−FITC antibody were added. After 60 min of incubation, unbound DAPI and 
antibody were removed and cells were washed once with PBS to reduce background staining. 
Cells were kept at 4 °C and the mitotic stages of fixed cells were examined by 
immunofluorescence microscopy. 
 
5.4 Kinase enrichment  
Affinity chromatography with the immobilized kinase inhibitors VI16832 [83], 
bisindolylmaleimide X (Alexis Biochemicals), AX14596 [122] SU6668 [123] and purvalanol 
B (Tocris) was done on an ÄKTA explorer system (GE Healthcare) as described except that 2 
volumes of 1.5 mM and 5 mM inhibitor solutions were reacted with 1 volume of epoxy-
activated Sepharose beads to generate the VI16832 and bisindolylmaleimide X affinity resins, 
respectively [83; 124]. Cell lysate was prepared as reported previously [124]and equal protein 
amounts of prometaphase, metaphase and telophase HeLa S cell extracts were combined 
prior to multi-resin affinity chromatography. Combined total cell extracts were loaded on the 
5 different inhibitor resins filled into three consecutive columns at a flow rate of 70 µl/min. 
The first and third column contained 0.5 ml of the V16832 and purvalanol B affinity resins, 
whereas the second column was packed with 0.33 ml of the SU6668, AX14596, and 
bisindolylmaleimide X matrices on top of each other. After sample loading and column 
washing, resin-bound proteins were eluted and concentrated as described previously[83]. 
(Kinase enrichment was done in association with Henrik Daub and Renate Hornberger). 
 
5.5 In-gel protein digestion 
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Around 700 µg of the kinase-enriched fraction was dissolved in LDS loading buffer and 
separated by SDS-PAGE using NuPAGE Novex Bis-Tris gels (Invitrogen) according to the 
manufacturer's instructions. The gel was stained with Coomassie blue and protein bands were 
visualized. The resulting lane was cut into around 15 slices which were then subjected to in-
gel digestion, essentially as described previously [125]. Gel slices were cut into small cubes of 
1 mm3 and washed with 50 mM ammonium bicarbonate (ABC) and 30% acetonitrile (ACN) 
until the cubes were fully destained. Gel cubes were dehydrated with 100% acetonitrile and 
rehydrated with 50 mM ABC containing 10 mM DTT. Proteins were reduced for 1 h at 56 
°C. Resulting free thiol groups were then alkylated by adding 55 mM iodoacetamide in 50 
mM ABC for 30 min at 25 °C in the dark. Gel pieces were washed twice with a 50 mM ABC 
solution, dehydrated with 100% acetonitrile, and dried in a vacuum concentrator. Each gel 
fraction was rehydrated in 50 mM ABC solution containing 15 ng/µl of trypsin, and samples 
were incubated at 37 °C overnight. Supernatants were transferred to new tubes, and residual 
peptides were extracted out of the gel pieces by double incubation with 30% ACN in 5% TFA 
and double incubation with 100% ACN. All extracts were combined, and ACN was 
evaporated in a vacuum concentrator. In case of experiment 3, peptides were analyzed twice 
(technical replicate). 
 
5.6 In-solution protein digestion 
 One third of the precipitated kinase-enriched fraction was directly dissolved in 20 mM 
HEPES buffer (pH 7.5) containing 7 M urea, and 2 M thiourea. Proteins were reduced by 
adding 2 mM DTT (final concentration) for 45 min at 25 °C, and thiols were 
carboxymethylated with 5.5 mM iodoacetamide for 30 min at room temperature. 
Endoproteinase Lys-C (Wako) was added in an enzyme/substrate ratio of 1:50 (5–6 µg of 
Lys-C), and the proteins were digested for 4 h at room temperature. The resulting peptide 
mixtures were diluted with water (1:4) to reduce the final urea concentration below 2 M. For 
double digestion, modified trypsin (sequencing grade, Roche) was added in an 
enzyme/substrate ratio of 1:50 (5–6 µg of trypsin), and the digest was incubated at 30 °C 
overnight. Trypsin activity was quenched by adding TFA to a final concentration of 1%.  
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5.7 Strong-cation exchange (SCX)  
The in-solution digests were loaded onto a strong-cation exchange (SCX) column 
(Polysulfoethyl, 1 x 150 mm, 5 µm particles, 200 Å pore size, PolyLC Inc.) using a Jasco 
2000-series HPLC system (Jasco Corporation). Peptides were separated by a linear 30 
minutes gradient between 100% buffer A (5 mM KH2PO4, pH 2.7, 33% ACN) and 30% 
buffer B (350 mM KCl, 5 mM KH2PO4, pH 2.7, 33% ACN) with a flow rate of 120 µL/min. 
60 seconds fractions were collected using an automated fraction collector. 
 
5.8 Phosphopeptide enrichment and desalting  
Titanium dioxide beads were used to selectively enrich for phosphorylated peptides with 
glycolic acid as a modifier [55]. About 3 mg of titanium dioxide beads were transferred to a 
GELoader tip (plugged at the constricted end by a small piece of C8 material) and washed 
with 40 µL of 80 µg/µL glycolic acid in a mixture of 80% ACN and 0.2% TFA. Digested 
peptides were dissolved in 20 µL of 80 µg/µL glycolic acid in a mixture of 80% ACN and 2% 
TFA and applied to microcolumns allowing phosphopeptides to bind to the titanium dioxide 
phase. Microcolumns were then washed with 40 µL of 80 µg/µL glycolic acid in a mixture of 
80% ACN and 0.2% TFA and 40 µL of a mixture of 80% ACN and 0.2% TFA (collected as 
flow-through). Finally, phosphorylated peptides were eluted slowly with 40 µL of 0.6% 
NH4OH and subsequently 40 µL of 60% ACN. Flow-through fractions were desalted with 
C18 reversed-phase material prior to LC-MS/MS analysis essentially as described [126]. 
 
5.9 Nano-LC-MS/MS Analysis 
All peptide samples were separated by online reverse phase nano-LC and analyzed by 
electrospray MS/MS. Using a nanoACQUITY ultra performance liquid chromatography 
system (Waters), samples were injected onto a 14-cm fused silica capillary column with an 
inner diameter of 75 µm and a tip of 8 µm (New Objective) packed in-house with 3-µm 
ReproSil-Pur C18-AQ (Dr. Maisch GmbH). The LC setup was connected to a LTQ-Orbitrap 
MS (Thermo Fisher Scientific) equipped with a nanoelectrospray ion source (Proxeon 
Biosystems). Peptides were separated and eluted by a stepwise 180 min gradient of 0−100% 
between buffer A (0.2% formic acid in water) and buffer B (0.2% formic acid in acetonitrile). 
Data-dependent acquisition was performed on the LTQ-Orbitrap using Xcalibur 2.0 software 
in the positive ion mode. Survey full scan MS spectra (from m/z 300 to 2000) were acquired 
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in the FT-Orbitrap with a resolution of 60 000 at m/z 400. A maximum of five peptides were 
sequentially isolated for fragmentation in the linear ion trap using collision induced 
dissociation (CID). The Orbitrap lock mass feature was applied to improve mass accuracy as 
described [59]. To improve phosphopeptide analysis, the multistage activation option in the 
software was enabled, and the neutral loss species at 97.97, 48.99, or 32.66 m/z below the 
precursor ion were activated for 30 ms during fragmentation (pseudo-MS3) [60].  
 
5.10 Data processing and analysis 
Raw data files were processed using the MaxQuant software suite (version 1.0.12.5) which 
performs, amongst other tasks, peak list generation, mass re-calibration, SILAC based 
quantitation, estimation of false discovery rates based on Mascot search results, and 
assembling peptides to protein groups[45]. Generation of peak lists was performed with the 
following MaxQuant parameters; top 12 MS/MS peaks for 100 Da, 3 data points for centroid, 
Gaussian centroid determination, slice peaks at local minima. During the peak list generation 
MaxQuant identified potential SILAC pairs based on mass differences of specified labeled 
amino acids, intensity correlation over elution time etc. Mascot (version 2.2.0, Matrix 
Science) was used for peptide identifications[88]. The initial precursor mass tolerance was set 
to ±7 ppm, whereas an accuracy of ±0.5 Da was used for MS/MS fragmentation spectra. 
Carbamidomethylation was set as fixed modification and methionine oxidation, protein N-
terminal acetylation, and phosphorylation (STY) were considered as variable modifications. 
Putative SILAC pairs are searched with their respective labeled amino acids as fixed 
modification whereas peaks which were not assigned to any of the SILAC pairs were 
searched using R6, R10, K4 and K8 as variable modifications. Enzyme specificity was set to 
Trypsin/P i.e. allowing cleavage N-terminal to proline in the context of [KR]P. Up to two 
missed cleavages were allowed. The minimum required peptide length was set to 6 amino 
acids. Searches were performed against IPI human (version 3.48; 71,400 protein entries) that 
was concatenated with reverse database sequences (142,800 protein entries in total) [127]. 
Further, MaxQuant filtered Mascot results using additional parameters, such as the number of 
labeled amino acids (max of 3) in the identified peptide sequence and the measured mass 
accuracy as a function of intensity [45]. As an additional quality measure to increase 
identification stringencies, we only accepted phosphorylation site identifications with Mascot 
scores of at least 12 or PTM scores of at least 30. Quantitation of SILAC pairs was performed 
with the following parameters; re-quantify, for protein quantitation discard unmodified 
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counterpart peptides except for oxidation and acetyl protein N-terminal, use razor and unique 
peptides, minimum ratio count of 1, minimum score 0, minimum peptides 1[45]. The initial 
maximum false-discovery rates (FDR) were set to 0.02, and 0.05 for peptides and proteins, 
respectively, and further reduced by Mascot score filtering as described above. FDR’s were 
calculated as (number of hits in the reversed database/number of hits in the forward database) 
× 100% [128].Whenever the set of identified peptides in one protein was equal to or 
completely contained in the set of identified peptides of another protein these two proteins 
were joined in a single protein group. Shared peptides are most parsimoniously associated 
with the group with the highest number of identified peptides ('razor' peptides [89]) but 
remain in all groups where they occur [45]. In cases where the peptides have more than one 
phosphorylation site, some of these phosphorylation sites are identified as multiply 
phosphorylated peptides whereas others are identified on multiple singly phosphorylated 
peptides. Different ratios of phosphorylation sites within the same peptide can only be 
determined if the different singly phosphorylated peptides eluted at different time points. In 
general, singly phosphorylated peptides are preferred for quantitation purposes compared to 
multiply phosphorylated peptides, since the individual contributions of multiple 
phosphorylation sites on the observed ratio of the phosphopeptide cannot be determined. 
SILAC data from BubR1 and Bub1 studies is analyzed using MSQuant [129]  
 
5.11 Interaction networks and functional clustering 
 Protein interaction networks were obtained from the STRING database version 8[74]using 
the web interface available at string.embl.de with the following parameters: required 
confidence, medium; network depth of 1; experiments and databases as prediction methods. 
Interaction data obtained from string database were loaded to Cytoscape [130] for drawing 
the images. Functional annotation clustering was done using DAVID Bioinformatics 
Resources [131]. Default parameters with medium classification stringency were used. 
 
5.12 Cell lysis and co-immunoprecipitation 
Cells were mixed with lysis buffer consisting of 50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-
40 (igepal), 0.1% deoxycholate, phosphatase inhibitor cocktails I and II (sigma), 30 ug/ml 
DNase, 30 ug/ml RNase and protease inhibitors (roche), to give a final protein concentration 
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of about 2 ug /ul.  Cells were left on ice for 10-20 minutes to lyse and then centrifuged at 
14,000 rpm to remove the cell debris.  
For co-immunoprecipitation, protein concentration of extract was measured and 
approximately 1 ug of antibody bound to protein G beads per 1 mg of protein extract is 
added.  Co-immunoprecipitation was carried out in the cold room for about 2 hours under 
constant mixing. Later beads are spun down and washed three times in the lysis buffer.  
Laemmli buffer was added to the beads and separated on SDS-PAGE. 
 
5.13 Kinase assay 
In vitro phosphorylation of recombinant BubR1 was carried out in 30 µl of kinase reaction 
buffer as previously described [87]. Recombinant active Cdk1 was purchased from Upstate 
Biotechnology, and GST-Mps1 from invitrogen. For Cdk1 assays on peptides immobilized 
cellulose membranes, dried membranes were first washed in ethanol and then hydrated in 
kinase buffer (50mM Tris-HCl pH7.5, 10 mM MgCl2, 1 mM DTT, 100 uM NaF, 10uM 
Sodium Vanadate) for 1 h, followed by overnight blocking in kinase buffer with 100mM 
NaCl and 0.5 mg/ml BSA. The next day, the membrane was blocked again with kinase buffer 
containing 1mg/ml BSA, 100 mM NaCl, and 50 µM cold ATP at 30°C for 45 min. The block 
was subsequently replaced with kinase reaction buffer containing 0.2 mg/ml BSA, 50 µCi/ml 
[γ-32P]ATP [3000 Ci/mmol, 10 mCi/ml], 2 µg/ml recombinant Cdk1, and 50 µM ATP for 3 
h on a shaker at 30°C. The membranes were then washed extensively: 10x 15 min in 1M 
NaCl, 3 x 5 min in H2O, 3 x  min 5% H3PO4 , 3 x 5 min in H2O, and then sonicated 
overnight in 8M urea, 1% SDS (w/v), and 0.5% (v/v) ß-mercaptoethanol to remove residual 
nonspecific radioactivity. Phosphorylation was visualized by autoradiography. 
For in-vitro Bub1 IP and kinase assay six 15 cm cell culture plates were transfected with 
myc-Bub1-WT and myc-Bub1-KD constructs, after 24 hrs nocodazole was added, and 16hr 
later cells are harvested. Co-immunoprecipitation and kinase assasys were performed 
separately, essentially as described above. After the co-immunoprecipitation beads were 
washed with lysis buffer with 300 mM NaCl followed by wash with 1X kinase reaction 
buffer without ATP. Then beads were incubated with 200 ul kinase reaction buffers with at 
30 °C for 60 minutes. Later beads were washed once with kinase reaction buffer without 
ATP, and beads from both the myc-Bub1-WT and myc-Bub1-KD were combined together. 
Laemmli buffer was added to the beads and separated on SDS-PAGE. 
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5.14 Peptide array synthesis and spots blotting 
Peptide arrays were constructed according to the Spots-synthesis method according the 
manufacturer’s directions (Intavis). For Cdc20 binding experiments, purified GST-Cdc20 
fusion protein generated in SF9 insect cells was added at 5 µg/ml in TBST and incubated 
together with the membrane overnight at 4 °C. Membranes were washed three times in TBST 
and bound protein was visualized with anti-Cdc20 antibodies. Sequences of peptides 
synthesized are as follows: KEN30: DEWELSKENVQPLRQ, KEN304: 
PPMPRAKENELQAGP, S543: SEKKNKSPPADP, S574: TSNEDVSPDVCD, S670: 
LSIKKLSPIIED, S720: SENPTQSPWCSQ, S1043: KVGKLTSPGALL.  
  
6.0 Appendix 
6.1 PPI network for proteins with upregulated phosphorylation sites
Figure S1: Picture depicting interactions between proteins with upregulated phosphorylation 
sites. The picture is generated using the STRING 
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interaction database. 
 
  
6.2 PPI network for proteins with 
Figure S2: Picture depicting interactions between proteins with 
phosphorylation sites. The picture is generated using the STRING interaction datab
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downregulated phosphorylation sites 
 
downregulated 
ase. 
  
84 
 
6.3 Supporting data available at tranche 
The following supporting data is saved at tranche: https://proteomecommons.org/tranche/. 
They can be accessed using their corresponding hash: 
Suppl. Data S3: SILAC ratios for proteins and phosphorylation sites 
lFQ3DPx0drMMnDH7TO8yLW3sDkGPm7GzCUNt9SqNUMdkTr7uRB21btU9inx173mgR
+xYJMHZreG+9nB/0ZDQ7YWqXp8AAAAAAAACbw== 
Suppl. Data S4: Reproducability between the biological replicates 
yZ4uG0EdwwuNvYMH+DqJ6jSnxTw2VsB6Mdq+jhd2iS4dv3hwI/jOeL8VQp1vT0swEGn
HlVRoqGmxSCJDZA9Pocf2GM4AAAAAAAACaA== 
Suppl. Data S5: Raw Files 
L4TzF0GZAYPyYmI+3GL6/WJ5JEyHg4uxtGNefDjSBlW9q2l1zxEVq1ZPkOj8wK9qvE0d
LcrqawRw3yVmqvGuXx/KLRYAAAAAAABYPA== 
Suppl. Data S6: MS/MS peak lists of the 117 raw data 
filesXZXixrydqHkFY0t6jDa25U0LuTQJ4E+7jnZK18O69QHLOwjoSdQitT04lGvBwOunW
PB5upvnLq8Ha6kl+MK2OZ02NWIAAAAAAAACOA== 
Suppl. Data S7: Annotated MS/MS spectra (based on full resolution profile data) of all 
phosphopeptides exported from MaxQuant 
r1SCPFUELrBZO0/8UnYyvIgOrIQA1LneEOdcWX4QpIp6yPA6VILahGA3WH0ctK8RFA
CLd1ZOeVeR9vhCHoLMr5QokDoAAAAAAAmLhA==  
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Abbreviations 
 
APC/C  Anaphase promoting complex/cyclosome 
ATP  Adenosine 5´-triphosphate  
BSA  Bovine serum albumin  
Bub1  Budding uninhibited by benzimidazole 1 
BubR1  Budding uninhibited by benzimidazole 1 homolog beta 
CDK1  Cyclin-dependent kinase 1 
CID  Collision induced dissociation 
C-terminus  Carboxyl terminus 
DAPI  4´,6-diamidino-2-phenylindole  
DMEM Dulbecco’s modified eagle’s medium 
DNA   Deoxyribonucleic Acid 
DTT  Dithiothreitol  
ECD  Electron capture dissociation 
ESI  Electrospray ionization 
ETD  Electron transfer dissociation 
FCS   Fetal calf serum 
FDR  False positive rates 
GO  Gene ontology 
HeLa S HeLa suspension cell line 
ICAT   Isotope coded affinity tag 
IMAC  Immobilized metal-ion affinity chromatography 
IP  Immunoprecipitation  
iTRAQ Isobaric tag for relative and absolute quantitation 
kDa   kilo Daltons 
MALDI Matrix-assisted laser desorption/ionization 
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MCC  Mmitotic checkpoint complex 
MOC  Metal-oxide chromatography 
mRNA  Messenger ribonucleic acid  
MS  Mass spectrometry 
N-terminus  Amino terminus 
PBS  Phosphate-buffered saline  
PMSF  phenylmethylsulfonyl fluoride  
PPI  Protein-protein interaction 
PRC1  Protein regulator of cytokinesis 
PTM  Posttranslational modification 
RF  Radio frequency 
SAC  Spindle assembly checkpoint 
SCX  Strong cation exchange 
SDS-PAGE Sodium dodecylsulfate polyacrylamide gelelectrophoresis  
SILAC  Stable isotope labeling with amino acids in cell culture 
siRNA  Small interference ribonucleic acid  
Tris   Tris(hydroxymethyl)-aminomethane 
WT  Wild-type 
  
  
87 
 
 
References 
 
[1]E.A. Nigg, Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol 
Cell Biol 2 (2001) 21-32. 
[2]A. Musacchio, E.D. Salmon, The spindle-assembly checkpoint in space and time. Nat Rev 
Mol Cell Biol 8 (2007) 379-393. 
[3]C.L. Rieder, R.W. Cole, A. Khodjakov, G. Sluder, The checkpoint delaying anaphase in 
response to chromosome monoorientation is mediated by an inhibitory signal 
produced by unattached kinetochores. J Cell Biol 130 (1995) 941-948. 
[4]D. Cimini, F. Degrassi, Aneuploidy: a matter of bad connections. Trends Cell Biol 15 
(2005) 442-451. 
[5]D. Morgan, The Cell Cycle: Principles of Control 1st edition ed., New Science Press Ltd, 
2007. 
[6]L.H. Hwang, L.F. Lau, D.L. Smith, C.A. Mistrot, K.G. Hardwick, E.S. Hwang, A. Amon, 
A.W. Murray, Budding yeast Cdc20: a target of the spindle checkpoint. Science 279 
(1998) 1041-1044. 
[7]S.H. Kim, D.P. Lin, S. Matsumoto, A. Kitazono, T. Matsumoto, Fission yeast Slp1: an 
effector of the Mad2-dependent spindle checkpoint. Science 279 (1998) 1045-1047. 
[8]D.W. Cleveland, Y. Mao, K.F. Sullivan, Centromeres and kinetochores: from epigenetics 
to mitotic checkpoint signaling. Cell 112 (2003) 407-421. 
[9]K.G. Hardwick, R.C. Johnston, D.L. Smith, A.W. Murray, MAD3 encodes a novel 
component of the spindle checkpoint which interacts with Bub3p, Cdc20p, and 
Mad2p. J Cell Biol 148 (2000) 871-882. 
  
88 
 
[10]R. Fraschini, A. Beretta, L. Sironi, A. Musacchio, G. Lucchini, S. Piatti, Bub3 interaction 
with Mad2, Mad3 and Cdc20 is mediated by WD40 repeats and does not require 
intact kinetochores. EMBO J 20 (2001) 6648-6659. 
[11]V. Sudakin, G.K. Chan, T.J. Yen, Checkpoint inhibition of the APC/C in HeLa cells is 
mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154 
(2001) 925-936. 
[12]P. Cohen, The origins of protein phosphorylation. Nat Cell Biol 4 (2002) E127-130. 
[13]J.D. Graves, E.G. Krebs, Protein phosphorylation and signal transduction. Pharmacol 
Ther 82 (1999) 111-121. 
[14]T. Pawson, J.D. Scott, Protein phosphorylation in signaling--50 years and counting. 
Trends Biochem Sci 30 (2005) 286-290. 
[15]G. Manning, D.B. Whyte, R. Martinez, T. Hunter, S. Sudarsanam, The protein kinase 
complement of the human genome. Science 298 (2002) 1912-1934. 
[16]V.M. Draviam, S. Orrechia, M. Lowe, R. Pardi, J. Pines, The localization of human 
cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme 
requires MEK to disassemble the Golgi apparatus. J Cell Biol 152 (2001) 945-958. 
[17]J.R. Bischoff, L. Anderson, Y. Zhu, K. Mossie, L. Ng, B. Souza, B. Schryver, P. 
Flanagan, F. Clairvoyant, C. Ginther, C.S. Chan, M. Novotny, D.J. Slamon, G.D. 
Plowman, A homologue of Drosophila aurora kinase is oncogenic and amplified in 
human colorectal cancers. EMBO J 17 (1998) 3052-3065. 
[18]K.E. Mundt, R.M. Golsteyn, H.A. Lane, E.A. Nigg, On the regulation and function of 
human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. 
Biochem Biophys Res Commun 239 (1997) 377-385. 
[19]J.A. Ubersax, J.E. Ferrell, Jr., Mechanisms of specificity in protein phosphorylation. Nat 
Rev Mol Cell Biol 8 (2007) 530-541. 
  
89 
 
[20]B. Nolen, S. Taylor, G. Ghosh, Regulation of protein kinases; controlling activity through 
activation segment conformation. Mol Cell 15 (2004) 661-675. 
[21]Y.J. Jang, S. Ma, Y. Terada, R.L. Erikson, Phosphorylation of threonine 210 and the role 
of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem 277 
(2002) 44115-44120. 
[22]W. Krek, E.A. Nigg, Cell cycle regulation of vertebrate p34cdc2 activity: identification 
of Thr161 as an essential in vivo phosphorylation site. New Biol 4 (1992) 323-329. 
[23]W. Krek, E.A. Nigg, Differential phosphorylation of vertebrate p34cdc2 kinase at the 
G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation 
sites. EMBO J 10 (1991) 305-316. 
[24]A.E. Elia, L.C. Cantley, M.B. Yaffe, Proteomic screen finds pSer/pThr-binding domain 
localizing Plk1 to mitotic substrates. Science 299 (2003) 1228-1231. 
[25]W. Qi, Z. Tang, H. Yu, Phosphorylation- and polo-box-dependent binding of Plk1 to 
Bub1 is required for the kinetochore localization of Plk1. Mol Biol Cell 17 (2006) 
3705-3716. 
[26]A.T. Saurin, J. Durgan, A.J. Cameron, A. Faisal, M.S. Marber, P.J. Parker, The regulated 
assembly of a PKCepsilon complex controls the completion of cytokinesis. Nat Cell 
Biol 10 (2008) 891-901. 
[27]R.M. Biondi, D. Komander, C.C. Thomas, J.M. Lizcano, M. Deak, D.R. Alessi, D.M. 
van Aalten, High resolution crystal structure of the human PDK1 catalytic domain 
defines the regulatory phosphopeptide docking site. EMBO J 21 (2002) 4219-4228. 
[28]N. Watanabe, H. Arai, Y. Nishihara, M. Taniguchi, T. Hunter, H. Osada, M-phase 
kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. 
Proc Natl Acad Sci U S A 101 (2004) 4419-4424. 
[29]T. Hunter, The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 
28 (2007) 730-738. 
  
90 
 
[30]J.J. Li, S.A. Li, Mitotic kinases: the key to duplication, segregation, and cytokinesis 
errors, chromosomal instability, and oncogenesis. Pharmacol Ther 111 (2006) 974-
984. 
[31]F.A. Barr, H.H. Sillje, E.A. Nigg, Polo-like kinases and the orchestration of cell division. 
Nat Rev Mol Cell Biol 5 (2004) 429-440. 
[32]T. Marumoto, D. Zhang, H. Saya, Aurora-A - a guardian of poles. Nat Rev Cancer 5 
(2005) 42-50. 
[33]P. Meraldi, R. Honda, E.A. Nigg, Aurora kinases link chromosome segregation and cell 
division to cancer susceptibility. Curr Opin Genet Dev 14 (2004) 29-36. 
[34]J. Tang, X. Yang, X. Liu, Phosphorylation of Plk1 at Ser326 regulates its functions 
during mitotic progression. Oncogene 27 (2008) 6635-6645. 
[35]R. Kittler, L. Pelletier, A.K. Heninger, M. Slabicki, M. Theis, L. Miroslaw, I. Poser, S. 
Lawo, H. Grabner, K. Kozak, J. Wagner, V. Surendranath, C. Richter, W. Bowen, 
A.L. Jackson, B. Habermann, A.A. Hyman, F. Buchholz, Genome-scale RNAi 
profiling of cell division in human tissue culture cells. Nat Cell Biol 9 (2007) 1401-
1412. 
[36]V.S. Edmond de Hoffmann, Mass Spectrometry: Principles and Applications 3 edition 
ed., Wiley-Interscience  2007. 
[37]M. Karas, D. Bachmann, F. Hillenkamp, Influence of the wavelength in high-irradiance 
ultraviolet laser desorption mass spectrometry of organic molecules. Analytical 
Chemistry 57 (1985) 2935-2939. 
[38]M. Karas, D. Bachmann, U. Bahr, F. Hillenkamp, Matrix-assisted ultraviolet laser 
desorption of non-volatile compounds. International Journal of Mass Spectrometry 
and Ion Processes 78 (1987) 53-68. 
[39]J.B. Fenn, M. Mann, C.K. Meng, S.F. Wong, C.M. Whitehouse, Electrospray ionization 
for mass spectrometry of large biomolecules. Science 246 (1989) 64-71. 
  
91 
 
[40]S.H. Paul W., Ein neues Massenspektrometer ohne Magnetfeld. RZeitschrift für 
Naturforschung 8 (1953) 3. 
[41]R. March, An Introduction to Quadrupole Ion Trap Mass Spectrometry. JOURNAL OF 
MASS SPECTROMETRY 32 (1997) 19. 
[42]Thermo Electron Corporation. Finnigan™ LTQ™ Hardware Manual. 
[43]A. Makarov, Electrostatic axially harmonic orbital trapping: a high-performance 
technique of mass analysis. Anal Chem 72 (2000) 1156-1162. 
[44]Q. Hu, R.J. Noll, H. Li, A. Makarov, M. Hardman, R. Graham Cooks, The Orbitrap: a 
new mass spectrometer. J Mass Spectrom 40 (2005) 430-443. 
[45]J. Cox, M. Mann, MaxQuant enables high peptide identification rates, individualized 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat 
Biotechnol 26 (2008) 1367-1372. 
[46]L.N. Mueller, O. Rinner, A. Schmidt, S. Letarte, B. Bodenmiller, M.Y. Brusniak, O. 
Vitek, R. Aebersold, M. Muller, SuperHirn - a novel tool for high resolution LC-MS-
based peptide/protein profiling. Proteomics 7 (2007) 3470-3480. 
[47]L.M. de Godoy, J.V. Olsen, J. Cox, M.L. Nielsen, N.C. Hubner, F. Frohlich, T.C. 
Walther, M. Mann, Comprehensive mass-spectrometry-based proteome quantification 
of haploid versus diploid yeast. Nature 455 (2008) 1251-1254. 
[48]M. Kruger, M. Moser, S. Ussar, I. Thievessen, C.A. Luber, F. Forner, S. Schmidt, S. 
Zanivan, R. Fassler, M. Mann, SILAC mouse for quantitative proteomics uncovers 
kindlin-3 as an essential factor for red blood cell function. Cell 134 (2008) 353-364. 
[49]T. Bonaldi, T. Straub, J. Cox, C. Kumar, P.B. Becker, M. Mann, Combined use of RNAi 
and quantitative proteomics to study gene function in Drosophila. Mol Cell 31 (2008) 
762-772. 
  
92 
 
[50]S.E. Ong, B. Blagoev, I. Kratchmarova, D.B. Kristensen, H. Steen, A. Pandey, M. Mann, 
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and 
accurate approach to expression proteomics. Mol Cell Proteomics 1 (2002) 376-386. 
[51]J. Reinders, A. Sickmann, State-of-the-art in phosphoproteomics. Proteomics 5 (2005) 
4052-4061. 
[52]J. Porath, J. Carlsson, I. Olsson, G. Belfrage, Metal chelate affinity chromatography, a 
new approach to protein fractionation. Nature 258 (1975) 598-599. 
[53]S.S. Jensen, M.R. Larsen, Evaluation of the impact of some experimental procedures on 
different phosphopeptide enrichment techniques. Rapid Commun Mass Spectrom 21 
(2007) 3635-3645. 
[54]T.E. Thingholm, O.N. Jensen, P.J. Robinson, M.R. Larsen, SIMAC (sequential elution 
from IMAC), a phosphoproteomics strategy for the rapid separation of 
monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics 7 
(2008) 661-671. 
[55]N. Sugiyama, T. Masuda, K. Shinoda, A. Nakamura, M. Tomita, Y. Ishihama, 
Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide 
chromatography for nano-LC-MS/MS in proteomics applications. Mol Cell 
Proteomics 6 (2007) 1103-1109. 
[56]Y. Kyono, N. Sugiyama, K. Imami, M. Tomita, Y. Ishihama, Successive and selective 
release of phosphorylated peptides captured by hydroxy acid-modified metal oxide 
chromatography. J Proteome Res 7 (2008) 4585-4593. 
[57]J.V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, M. Mann, Global, 
in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127 
(2006) 635-648. 
[58]R.S. Annan, M.J. Huddleston, R. Verma, R.J. Deshaies, S.A. Carr, A multidimensional 
electrospray MS-based approach to phosphopeptide mapping. Anal Chem 73 (2001) 
393-404. 
  
93 
 
[59]A. Gruhler, J.V. Olsen, S. Mohammed, P. Mortensen, N.J. Faergeman, M. Mann, O.N. 
Jensen, Quantitative phosphoproteomics applied to the yeast pheromone signaling 
pathway. Mol Cell Proteomics 4 (2005) 310-327. 
[60]M.J. Schroeder, J. Shabanowitz, J.C. Schwartz, D.F. Hunt, J.J. Coon, A neutral loss 
activation method for improved phosphopeptide sequence analysis by quadrupole ion 
trap mass spectrometry. Anal Chem 76 (2004) 3590-3598. 
[61]J. Cox, M. Mann, Is proteomics the new genomics? Cell 130 (2007) 395-398. 
[62]M. Ashburner, C. Ball, J. Blake, D. Botstein, H. Butler, J. Cherry, A. Davis, K. Dolinski, 
S. Dwight, J. Eppig, M. Harris, D. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. 
Matese, J. Richardson, M. Ringwald, G. Rubin, G. Sherlock, Gene ontology: tool for 
the unification of biology. The Gene Ontology Consortium. Nat Genet 25 (2000) 25-
29. 
[63]G.J. Dennis, B. Sherman, D. Hosack, J. Yang, W. Gao, H. Lane, R. Lempicki, DAVID: 
Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 
(2003) P3. 
[64]M. Cary, G. Bader, C. Sander, Pathway information for systems biology. FEBS Lett 579 
(2005) 1815-1820. 
[65]M. Kanehisa, M. Araki, S. Goto, M. Hattori, M. Hirakawa, M. Itoh, T. Katayama, S. 
Kawashima, S. Okuda, T. Tokimatsu, Y. Yamanishi, KEGG for linking genomes to 
life and the environment. Nucleic Acids Res 36 (2008) D480-484. 
[66]I. Vastrik, P. D'Eustachio, E. Schmidt, G. Joshi-Tope, G. Gopinath, D. Croft, B. de Bono, 
M. Gillespie, B. Jassal, S. Lewis, L. Matthews, G. Wu, E. Birney, L. Stein, Reactome: 
a knowledge base of biologic pathways and processes. Genome Biol 8 (2007) R39. 
[67]N. Gough, Science's signal transduction knowledge environment: the connections maps 
database. Ann N Y Acad Sci 971 (2002) 585-587. 
  
94 
 
[68]P. Thomas, A. Kejariwal, M. Campbell, H. Mi, K. Diemer, N. Guo, I. Ladunga, B. 
Ulitsky-Lazareva, A. Muruganujan, S. Rabkin, J. Vandergriff, O. Doremieux, 
PANTHER: a browsable database of gene products organized by biological function, 
using curated protein family and subfamily classification. Nucleic Acids Res 31 
(2003) 334-341. 
[69]N. Le Novère, B. Bornstein, A. Broicher, M. Courtot, M. Donizelli, H. Dharuri, L. Li, H. 
Sauro, M. Schilstra, B. Shapiro, J. Snoep, M. Hucka, BioModels Database: a free, 
centralized database of curated, published, quantitative kinetic models of biochemical 
and cellular systems. Nucleic Acids Res 34 (2006) D689-691. 
[70]N. Salomonis, K. Hanspers, A. Zambon, K. Vranizan, S. Lawlor, K. Dahlquist, S. 
Doniger, J. Stuart, B. Conklin, A. Pico, GenMAPP 2: new features and resources for 
pathway analysis. BMC Bioinformatics 8 (2007) 217. 
[71]C. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, T. Hannay, K. Buetow, PID: the 
Pathway Interaction Database. Nucleic Acids Res 37 (2009) D674-679. 
[72]F. Al-Shahrour, P. Minguez, J. Tárraga, D. Montaner, E. Alloza, J. Vaquerizas, L. Conde, 
C. Blaschke, J. Vera, J. Dopazo, BABELOMICS: a systems biology perspective in the 
functional annotation of genome-scale experiments. Nucleic Acids Res 34 (2006) 
W472-476. 
[73]R. Zaidel-Bar, S. Itzkovitz, A. Ma'ayan, R. Iyengar, B. Geiger, Functional atlas of the 
integrin adhesome. Nat Cell Biol 9 (2007) 858-867. 
[74]L. Jensen, M. Kuhn, M. Stark, S. Chaffron, C. Creevey, J. Muller, T. Doerks, P. Julien, 
A. Roth, M. Simonovic, P. Bork, C. von Mering, STRING 8--a global view on 
proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37 
(2009) D412-416. 
[75]T. Prasad, K. Kandasamy, A. Pandey, Human Protein Reference Database and Human 
Proteinpedia as discovery tools for systems biology. Methods Mol Biol 577 (2009) 
67-79. 
  
95 
 
[76]S. Kerrien, Y. Alam-Faruque, B. Aranda, I. Bancarz, A. Bridge, C. Derow, E. Dimmer, 
M. Feuermann, A. Friedrichsen, R. Huntley, C. Kohler, J. Khadake, C. Leroy, A. 
Liban, C. Lieftink, L. Montecchi-Palazzi, S. Orchard, J. Risse, K. Robbe, B. Roechert, 
D. Thorneycroft, Y. Zhang, R. Apweiler, H. Hermjakob, IntAct--open source resource 
for molecular interaction data. Nucleic Acids Res 35 (2007) D561-565. 
[77]M. Persico, A. Ceol, C. Gavrila, R. Hoffmann, A. Florio, G. Cesareni, HomoMINT: an 
inferred human network based on orthology mapping of protein interactions 
discovered in model organisms. BMC Bioinformatics 6 Suppl 4 (2005) S21. 
[78]C. Alfarano, C. Andrade, K. Anthony, N. Bahroos, M. Bajec, K. Bantoft, D. Betel, B. 
Bobechko, K. Boutilier, E. Burgess, K. Buzadzija, R. Cavero, C. D'Abreo, I. 
Donaldson, D. Dorairajoo, M. Dumontier, M. Dumontier, V. Earles, R. Farrall, H. 
Feldman, E. Garderman, Y. Gong, R. Gonzaga, V. Grytsan, E. Gryz, V. Gu, E. 
Haldorsen, A. Halupa, R. Haw, A. Hrvojic, L. Hurrell, R. Isserlin, F. Jack, F. Juma, 
A. Khan, T. Kon, S. Konopinsky, V. Le, E. Lee, S. Ling, M. Magidin, J. Moniakis, J. 
Montojo, S. Moore, B. Muskat, I. Ng, J. Paraiso, B. Parker, G. Pintilie, R. Pirone, J. 
Salama, S. Sgro, T. Shan, Y. Shu, J. Siew, D. Skinner, K. Snyder, R. Stasiuk, D. 
Strumpf, B. Tuekam, S. Tao, Z. Wang, M. White, R. Willis, C. Wolting, S. Wong, A. 
Wrong, C. Xin, R. Yao, B. Yates, S. Zhang, K. Zheng, T. Pawson, B. Ouellette, C. 
Hogue, The Biomolecular Interaction Network Database and related tools 2005 
update. Nucleic Acids Res 33 (2005) D418-424. 
[79]L. Salwinski, C. Miller, A. Smith, F. Pettit, J. Bowie, D. Eisenberg, The Database of 
Interacting Proteins: 2004 update. Nucleic Acids Res 32 (2004) D449-451. 
[80]B. Breitkreutz, C. Stark, T. Reguly, L. Boucher, A. Breitkreutz, M. Livstone, R. 
Oughtred, D. Lackner, J. Bähler, V. Wood, K. Dolinski, M. Tyers, The BioGRID 
Interaction Database: 2008 update. Nucleic Acids Res 36 (2008) D637-640. 
[81]S.A. Johnson, T. Hunter, Kinomics: methods for deciphering the kinome. Nat Methods 2 
(2005) 17-25. 
  
96 
 
[82]T.B. Schreiber, N. Mausbacher, S.B. Breitkopf, K. Grundner-Culemann, H. Daub, 
Quantitative phosphoproteomics--an emerging key technology in signal-transduction 
research. Proteomics 8 (2008) 4416-4432. 
[83]H. Daub, J.V. Olsen, M. Bairlein, F. Gnad, F.S. Oppermann, R. Korner, Z. Greff, G. 
Keri, O. Stemmann, M. Mann, Kinase-selective enrichment enables quantitative 
phosphoproteomics of the kinome across the cell cycle. Mol Cell 31 (2008) 438-448. 
[84]M. Bantscheff, D. Eberhard, Y. Abraham, S. Bastuck, M. Boesche, S. Hobson, T. 
Mathieson, J. Perrin, M. Raida, C. Rau, V. Reader, G. Sweetman, A. Bauer, T. 
Bouwmeester, C. Hopf, U. Kruse, G. Neubauer, N. Ramsden, J. Rick, B. Kuster, G. 
Drewes, Quantitative chemical proteomics reveals mechanisms of action of clinical 
ABL kinase inhibitors. Nat Biotechnol 25 (2007) 1035-1044. 
[85]M. Mann, Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 7 
(2006) 952-958. 
[86]N. Dephoure, C. Zhou, J. Villén, S. Beausoleil, C. Bakalarski, S. Elledge, S. Gygi, A 
quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105 (2008) 
10762-10767. 
[87]S. Elowe, S. Hummer, A. Uldschmid, X. Li, E.A. Nigg, Tension-sensitive Plk1 
phosphorylation on BubR1 regulates the stability of kinetochore microtubule 
interactions. Genes Dev 21 (2007) 2205-2219. 
[88]D.N. Perkins, D.J. Pappin, D.M. Creasy, J.S. Cottrell, Probability-based protein 
identification by searching sequence databases using mass spectrometry data. 
Electrophoresis 20 (1999) 3551-3567. 
[89]A.I. Nesvizhskii, R. Aebersold, Interpretation of shotgun proteomic data: the protein 
inference problem. Mol Cell Proteomics 4 (2005) 1419-1440. 
[90]http://kinase.com/, in. 
  
97 
 
[91]V. Vulsteke, M. Beullens, A. Boudrez, S. Keppens, A. Van Eynde, M.H. Rider, W. 
Stalmans, M. Bollen, Inhibition of spliceosome assembly by the cell cycle-regulated 
protein kinase MELK and involvement of splicing factor NIPP1. J Biol Chem 279 
(2004) 8642-8647. 
[92]W. Ma, J.A. Koch, M.M. Viveiros, Protein kinase C delta (PKCdelta) interacts with 
microtubule organizing center (MTOC)-associated proteins and participates in meiotic 
spindle organization. Dev Biol 320 (2008) 414-425. 
[93]D. Morgan, The Cell Cycle: Principles of Control (Primers in Biology). , New Science 
Press Ltd, 2007. 
[94]T.W. Sturgill, MAP kinase: it's been longer than fifteen minutes. Biochem Biophys Res 
Commun 371 (2008) 1-4. 
[95]F.S. Willard, M.F. Crouch, MEK, ERK, and p90RSK are present on mitotic tubulin in 
Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit. Cell 
Signal 13 (2001) 653-664. 
[96]M. Shinohara, A.V. Mikhailov, J.A. Aguirre-Ghiso, C.L. Rieder, Extracellular signal-
regulated kinase 1/2 activity is not required in mammalian cells during late G2 for 
timely entry into or exit from mitosis. Mol Biol Cell 17 (2006) 5227-5240. 
[97]H. Cha, X. Wang, H. Li, A.J. Fornace, Jr., A functional role for p38 MAPK in 
modulating mitotic transit in the absence of stress. J Biol Chem 282 (2007) 22984-
22992. 
[98]C.B. Campos, P.A. Bedard, R. Linden, Activation of p38 mitogen-activated protein 
kinase during normal mitosis in the developing retina. Neuroscience 112 (2002) 583-
591. 
[99]A. Mikhailov, M. Shinohara, C.L. Rieder, Topoisomerase II and histone deacetylase 
inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint 
pathway. J Cell Biol 166 (2004) 517-526. 
  
98 
 
[100]S. Kauffman, J.J. Wille, The mitotic oscillator in Physarum polycephalum. J Theor Biol 
55 (1975) 47-93. 
[101]A.W. Murray, M.J. Solomon, M.W. Kirschner, The role of cyclin synthesis and 
degradation in the control of maturation promoting factor activity. Nature 339 (1989) 
280-286. 
[102]F.S. Oppermann, F. Gnad, J.V. Olsen, R. Hornberger, Z. Greff, G. Keri, M. Mann, H. 
Daub, Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8 
(2009) 1751-1764. 
[103]M. Murata-Hori, M. Tatsuka, Y.L. Wang, Probing the dynamics and functions of aurora 
B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 13 (2002) 1099-
1108. 
[104]R. Gassmann, A. Carvalho, A.J. Henzing, S. Ruchaud, D.F. Hudson, R. Honda, E.A. 
Nigg, D.L. Gerloff, W.C. Earnshaw, Borealin: a novel chromosomal passenger 
required for stability of the bipolar mitotic spindle. J Cell Biol 166 (2004) 179-191. 
[105]R. Neef, U. Gruneberg, R. Kopajtich, X. Li, E.A. Nigg, H. Sillje, F.A. Barr, Choice of 
Plk1 docking partners during mitosis and cytokinesis is controlled by the activation 
state of Cdk1. Nat Cell Biol 9 (2007) 436-444. 
[106]E.W. Wilker, M.A. van Vugt, S.A. Artim, P.H. Huang, C.P. Petersen, H.C. Reinhardt, 
Y. Feng, P.A. Sharp, N. Sonenberg, F.M. White, M.B. Yaffe, 14-3-3sigma controls 
mitotic translation to facilitate cytokinesis. Nature 446 (2007) 329-332. 
[107]M.A. Hoyt, L. Totis, B.T. Roberts, S. cerevisiae genes required for cell cycle arrest in 
response to loss of microtubule function. Cell 66 (1991) 507-517. 
[108]G.J. Kops, B.A. Weaver, D.W. Cleveland, On the road to cancer: aneuploidy and the 
mitotic checkpoint. Nat Rev Cancer 5 (2005) 773-785. 
  
99 
 
[109]S. Matsumura, F. Toyoshima, E. Nishida, Polo-like kinase 1 facilitates chromosome 
alignment during prometaphase through BubR1. J Biol Chem 282 (2007) 15217-
15227. 
[110]M.A. Lampson, T.M. Kapoor, The human mitotic checkpoint protein BubR1 regulates 
chromosome-spindle attachments. Nat Cell Biol 7 (2005) 93-98. 
[111]Z. Tang, H. Shu, D. Oncel, S. Chen, H. Yu, Phosphorylation of Cdc20 by Bub1 
provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol 
Cell 16 (2004) 387-397. 
[112]H. Huang, T.J. Yen, BubR1 is an effector of multiple mitotic kinases that specifies 
kinetochore: microtubule attachments and checkpoint. Cell Cycle 8 (2009) 1164-
1167. 
[113]S.A. Kawashima, Y. Yamagishi, T. Honda, K. Ishiguro, Y. Watanabe, Phosphorylation 
of H2A by Bub1 prevents chromosomal instability through localizing shugoshin. 
Science 327 (2010) 172-177. 
[114]T.B. Schreiber, N. Mausbacher, G. Keri, J. Cox, H. Daub, An integrated 
phosphoproteomics workflow reveals extensive network regulation in early 
lysophosphatidic acid signaling. Mol Cell Proteomics (2010). 
[115]K. Sharma, C. Weber, M. Bairlein, Z. Greff, G. Keri, J. Cox, J.V. Olsen, H. Daub, 
Proteomics strategy for quantitative protein interaction profiling in cell extracts. Nat 
Methods 6 (2009) 741-744. 
[116]H.H. Sillje, E.A. Nigg, Purification of mitotic spindles from cultured human cells. 
Methods 38 (2006) 25-28. 
[117]A.M. Bentley, G. Normand, J. Hoyt, R.W. King, Distinct sequence elements of cyclin 
B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis. 
Mol Biol Cell 18 (2007) 4847-4858. 
  
100 
 
[118]Q. Chen, X. Zhang, Q. Jiang, P.R. Clarke, C. Zhang, Cyclin B1 is localized to 
unattached kinetochores and contributes to efficient microtubule attachment and 
proper chromosome alignment during mitosis. Cell Res 18 (2008) 268-280. 
[119]S. Elowe, K. Dulla, A. Uldschmid, X. Li, Z. Dou, E.A. Nigg, Uncoupling of the spindle-
checkpoint and chromosome-congression functions of BubR1. J Cell Sci 123 (2010) 
84-94. 
[120]F. Gao, J.F. Ponte, M. Levy, P. Papageorgis, N.M. Cook, S. Ozturk, A.W. Lambert, A. 
Thiagalingam, H.M. Abdolmaleky, B.A. Sullivan, S. Thiagalingam, hBub1 negatively 
regulates p53 mediated early cell death upon mitotic checkpoint activation. Cancer 
Biol Ther 8 (2009) 548-556. 
[121]C.E. Bakalarski, J.E. Elias, J. Villen, W. Haas, S.A. Gerber, P.A. Everley, S.P. Gygi, 
The impact of peptide abundance and dynamic range on stable-isotope-based 
quantitative proteomic analyses. J Proteome Res 7 (2008) 4756-4765. 
[122]D. Brehmer, Z. Greff, K. Godl, S. Blencke, A. Kurtenbach, M. Weber, S. Muller, B. 
Klebl, M. Cotten, G. Keri, J. Wissing, H. Daub, Cellular targets of gefitinib. Cancer 
Res 65 (2005) 379-382. 
[123]K. Godl, O.J. Gruss, J. Eickhoff, J. Wissing, S. Blencke, M. Weber, H. Degen, D. 
Brehmer, L. Orfi, Z. Horvath, G. Keri, S. Muller, M. Cotten, A. Ullrich, H. Daub, 
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple 
impacts on cellular kinase signaling. Cancer Res 65 (2005) 6919-6926. 
[124]J. Wissing, L. Jansch, M. Nimtz, G. Dieterich, R. Hornberger, G. Keri, J. Wehland, H. 
Daub, Proteomics analysis of protein kinases by target class-selective prefractionation 
and tandem mass spectrometry. Mol Cell Proteomics 6 (2007) 537-547. 
[125]A. Shevchenko, M. Wilm, O. Vorm, M. Mann, Mass spectrometric sequencing of 
proteins silver-stained polyacrylamide gels. Anal Chem 68 (1996) 850-858. 
  
101 
 
[126]J. Rappsilber, Y. Ishihama, M. Mann, Stop and go extraction tips for matrix-assisted 
laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in 
proteomics. Anal Chem 75 (2003) 663-670. 
[127]J.E. Elias, S.P. Gygi, Target-decoy search strategy for increased confidence in large-
scale protein identifications by mass spectrometry. Nat Methods 4 (2007) 207-214. 
[128]H. Choi, A.I. Nesvizhskii, False discovery rates and related statistical concepts in mass 
spectrometry-based proteomics. J Proteome Res 7 (2008) 47-50. 
[129]P. Mortensen, J.W. Gouw, J.V. Olsen, S.E. Ong, K.T. Rigbolt, J. Bunkenborg, J. Cox, 
L.J. Foster, A.J. Heck, B. Blagoev, J.S. Andersen, M. Mann, MSQuant, an open 
source platform for mass spectrometry-based quantitative proteomics. J Proteome Res 
9 (2010) 393-403. 
[130]P. Shannon, A. Markiel, O. Ozier, N. Baliga, J. Wang, D. Ramage, N. Amin, B. 
Schwikowski, T. Ideker, Cytoscape: a software environment for integrated models of 
biomolecular interaction networks. Genome Res 13 (2003) 2498-2504. 
[131]W. Huang da, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources. Nat Protoc 4 (2009) 44-57. 
 
 
  
  
102 
 
Acknowledgements 
It gives me immense pleasure to introduce the people who are pivotal in the successful 
completion of this thesis.  
First and foremost I would like to thank Prof. Dr. Erich A. Nigg for giving me opportunity to 
work in highly interdisciplinary, motivating and international scientific environment. His 
supervision, inputs and support helped me immensely in shaping up the project and also to 
finish it in a timely manner.  
I also thank Erich and Elena Nigg for the kind invitation to their family at the beginning of 
my stay in Germany and also the support in times of difficulty. I really appreciate that. 
Further, I am highly indebted to Dr. Roman Koerner, our group leader, for his constant 
guidance, scientific freedom and support in professional and personal matters which made the 
time I spent at MPIB a very pleasant and fruitful learning experience. He is undoubtedly the 
best supervisors one could ever ask for.  
I thank Dr. Anna Santamaria for her guidance and support throughout my time at MPIB. I 
treasure her friendship. 
I grateful to Albert Ries for helping me on numerous occasions in day to day lab matters.  
A special thanks to the members of our mass spectrometry group viz Dr. Rainer Malik, Bin 
Wang, and Dr. Rene Lenobel for all the discussions and help. 
I am thankful to Ms. Alison Dalfovo for her assistance with my paperwork. I also thank her 
for all the help and kind suggestions she gave. 
 I would like to thank my collaborators Dr. Henrik Daub, Renate Hornberger for kinase 
project and Dr. Sabine Elowe for BubR1, Bub1 project. I also thank her for helping in the 
preparation of this thesis. 
I thank Prof. Dr. Matthias Mann and Dr. Jürgen Cox for early access to the MaxQuant 
software package. 
I want to thank all the members of Erich Nigg’s department members for creating such an 
inspiring and pleasant atmosphere in the lab.  
Lastly, I would like to thank all my friends and family members. Without you it wouldn’t 
have been possible.  
  
  
103 
 
Publications 
 
 
Parts of this work are published in: 
K. Dulla, H. Daub, R. Hornberger, E.A. Nigg, R. Korner, Quantitative site-specific 
phosphorylation dynamics of human protein kinases during mitotic progression. ( in press 
Mol Cell Proteomics 2010). 
S. Elowe, K. Dulla, A. Uldschmid, X. Li, Z. Dou, E.A. Nigg, Uncoupling of the spindle-
checkpoint and chromosome-congression functions of BubR1. J Cell Sci 123 (2010) 84-94. 
R. Malik, K. Dulla, E.A. Nigg, R. Korner, From proteome lists to biological impact- tools 
and strategies for the analysis of large MS data sets. (Review article, in press Proteomics 
2010). 
  
  
104 
 
Curriculum Vitae 
 
Kalyana Dulla 
Date and place of birth: 11.11.1982, Vijayawada 
 
 
 
Education 
 
11.06 - 01.10 DEPARTMENT OF CELL BIOLOGY, MAX PLANCK INSTITUTE OF 
BIOCHEMISTRY, MARTINSRIED, GERMANY 
PhD thesis with Prof. Dr. Erich A. Nigg: Analysis of mitotic 
phosphoproteomes using SILAC based mass spectrometry. 
08.05 - 11.06 CENTER FOR CELLULAR AND MOLECULAR BIOLOGY, 
HYDERABAD, INDIA 
Research Fellow with Dr. Ravi Sirdeshmukh. Proteomics group.   
08.03 - 06.05 INDIAN INSTITUTE OF TECHNOLOGY ROORKEE (IIT ROORKEE), 
INDIA        
Masters in Biotechnology (grade point 7.94/10) 
07.00 - 06.03 PB SIDHARDHA COLLEGE, NAGARJUNA UNIVERSITY, INDIA 
Bachelors in Science with the subjects Genetics, Chemistry and Botany 
(grade 86.00 %) 
06.98 - 05.00 INTERMEDIATE BOARD, ANDHRA PRADESH , INDIA 
Botany, Zoology, Chemistry, Physics 88.00 % 
06.88 - 05.98 
 
 Secondary School Certificate, Board of Secondary Education, Andhra 
Pradesh, INDIA 
84.00 % 
 
 
 
 
  
105 
 
Awards 
• 02.10 – Marie Curie Fellowship 
• 11.06 - 01.10: Receiver of Max Planck Society Fellowship, Germany 
• 08.05 - 11.06: Receiver of CSIR Research Fellowship, India. 
• 08.03 - 06.05: Receiver of Merit Scholarship from Department of Biotechnology,              
under the Ministry of Education, Government of India. 
 
 
Conferences and workshops 
• Phospho-Proteomics Seminar with Practical Workshop, Vienna 2008, 13 -14 October. 
Oral Presentation 
• HUPO 7th Annual World Congress, Amsterdam 2008, 16 - 20 August. Poster 
Presentation 
• ENFIN Annual General Meeting. Rome 2008, 5-6 March. Poster Presentation 
• Summer school on "Advanced Statistics and Data Mining". Madrid 2009, 13-17 July. 
 
 
 
